PRE 14A · 2026-10-30
China Pharma Holdings, Inc. announces its Annual Meeting set for December 22, 2026, with key votes on director elections and a reverse stock split.
| Name | CHINA PHARMA HOLDINGS, INC. |
|---|---|
| CIK | 0001106644 |
| Tickers | CPHI |
| Exchanges | NYSE |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 731564807 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | 8689866811730 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
China Pharma Holdings, Inc. announces its Annual Meeting set for December 22, 2026, with key votes on director elections and a reverse stock split.
429 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-18 | 10-Q | QUARTERLY REPORT | 0001213900-26-121812 | 001-34471 | 261570491 | 34 | 4752227 | 1 | 1 | |
| 2026-11-17 | NT 10-Q | NOTIFICATION OF LATE FILING | 0001213900-26-121329 | 001-34471 | 261565524 | 34 | 22631 | |||
| 2026-11-10 | DEF 14A | DEFINITIVE PROXY STATEMENT | 0001213900-26-118012 | 001-34471 | 261540271 | 34 | 2630010 | |||
| 2026-10-30 | PRE 14A | PRELIMINARY PROXY STATEMENT | 0001213900-26-114445 | 001-34471 | 261508601 | 34 | 213143 | |||
| 2026-08-14 | 10-Q | QUARTERLY REPORT | 0001213900-26-090173 | 001-34471 | 261282680 | 34 | 4666110 | 1 | 1 | |
| 2026-07-23 | 424B5 | PROSPECTUS SUPPLEMENT | 0001213900-26-080581 | 333-276481 | 261195107 | 33 | 459051 | |||
| 2026-07-22 | 8-K | CURRENT REPORT | 1.01,8.01,9.01 | 0001213900-26-080475 | 001-34471 | 261194565 | 34 | 669705 | 1 | 1 |
| 2026-05-15 | 10-Q | QUARTERLY REPORT | 0001213900-26-057705 | 001-34471 | 26987093 | 34 | 4112384 | 1 | 1 | |
| 2026-04-01 | 10-K | ANNUAL REPORT | 0001213900-26-038521 | 001-34471 | 26828362 | 34 | 6704830 | 1 | 1 | |
| 2026-04-01 | NT 10-K | NOTIFICATION OF LATE FILING | 0001213900-26-038495 | 001-34471 | 26828091 | 34 | 23453 | |||
| 2026-03-03 | 8-K | CURRENT REPORT | 1.01,3.02,9.01 | 0001213900-26-023022 | 001-34471 | 26713916 | 34 | 238086 | 1 | 1 |
| 2026-02-10 | 8-K | CURRENT REPORT | 1.01,3.02,9.01 | 0001213900-26-014338 | 001-34471 | 26616801 | 34 | 224983 | 1 | 1 |
| 2026-01-06 | 8-K | CURRENT REPORT | 5.07 | 0001213900-26-001785 | 001-34471 | 26511438 | 34 | 200859 | 1 | 1 |
| 2025-12-23 | 8-K | FORM 8-K | 1.01,3.02 | 0001213900-25-125299 | 001-34471 | 251600535 | 34 | 192596 | 1 | 1 |
| 2025-12-10 | 8-K | CURRENT REPORT | 1.01,3.02 | 0001213900-25-120129 | 001-34471 | 251562532 | 34 | 194337 | 1 | 1 |
| 2025-11-14 | DEF 14A | DEFINITIVE PROXY STATEMENT | 0001213900-25-110882 | 001-34471 | 251486770 | 34 | 1820035 | |||
| 2025-11-12 | 10-Q | QUARTERLY REPORT | 0001213900-25-109203 | 001-34471 | 251472777 | 34 | 4163570 | 1 | 1 | |
| 2025-11-04 | PRE 14A | PRELIMINARY PROXY STATEMENT | 0001213900-25-106092 | 001-34471 | 251448913 | 34 | 218770 | |||
| 2025-08-14 | 10-Q | QUARTERLY REPORT | 0001213900-25-076642 | 001-34471 | 251218857 | 34 | 4147932 | 1 | 1 | |
| 2025-05-14 | 10-Q | QUARTERLY REPORT | 0001213900-25-043334 | 001-34471 | 25946014 | 34 | 4122531 | 1 | 1 | |
| 2025-04-04 | 8-K | CURRENT REPORT | 7.01,9.01 | 0001213900-25-029000 | 001-34471 | 25813960 | 34 | 211101 | 1 | 1 |
| 2025-03-31 | 10-K | ANNUAL REPORT | 0001213900-25-026280 | 001-34471 | 25793571 | 34 | 6216106 | 1 | 1 | |
| 2024-12-26 | 8-K | CURRENT REPORT | 1.02 | 0001213900-24-112685 | 001-34471 | 241581373 | 34 | 198519 | 1 | 1 |
| 2024-12-26 | 8-K | CURRENT REPORT | 5.07 | 0001213900-24-112658 | 001-34471 | 241581071 | 34 | 215365 | 1 | 1 |
| 2024-12-13 | 8-K | CURRENT REPORT | 1.01,9.01 | 0001213900-24-108617 | 001-34471 | 241546875 | 34 | 366323 | 1 | 1 |
| 2024-12-13 | 424B5 | PROSPECTUS SUPPLEMENT | 0001213900-24-108616 | 333-276481 | 241546867 | 33 | 395466 | |||
| 2024-11-13 | 10-Q | QUARTERLY REPORT | 0001213900-24-097461 | 001-34471 | 241454083 | 34 | 4521847 | 1 | 1 | |
| 2024-11-12 | DEF 14A | DEFINITIVE PROXY STATEMENT | 0001213900-24-096780 | 001-34471 | 241447958 | 34 | 2810981 | |||
| 2024-11-01 | PRE 14A | PRELIMINARY PROXY STATEMENT | 0001213900-24-093490 | 001-34471 | 241419074 | 34 | 230955 | |||
| 2024-08-14 | 10-Q | QUARTERLY REPORT | 0001213900-24-068984 | 001-34471 | 241207478 | 34 | 4369170 | 1 | 1 | |
| 2024-05-30 | 8-K | CURRENT REPORT | 1.01,9.01 | 0001213900-24-047965 | 001-34471 | 241005164 | 34 | 228987 | 1 | 1 |
| 2024-05-15 | 10-Q | QUARTERLY REPORT | 0001213900-24-043591 | 001-34471 | 24950434 | 34 | 4033295 | 1 | 1 | |
| 2024-05-08 | 8-K | FORM 8-K | 4.01 | 0001213900-24-040851 | 001-34471 | 24925823 | 34 | 203646 | 1 | 1 |
| 2024-04-01 | 10-K | ANNUAL REPORT | 0001213900-24-028731 | 001-34471 | 24809157 | 34 | 10639976 | 1 | 1 | |
| 2024-03-29 | 8-K | FORM 8-K | 8.01 | 0001213900-24-027972 | 001-34471 | 24804143 | 34 | 197625 | 1 | 1 |
| 2024-02-23 | 8-K | CURRENT REPORT | 7.01,9.01 | 0001213900-24-016507 | 001-34471 | 24671137 | 34 | 208663 | 1 | 1 |
| 2024-02-14 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2024-02-14 16:00:00 | 9999999995-24-000463 | 333-276481 | 24641885 | 33 | 2081 | ||
| 2024-02-14 | CORRESP | filename1.htm | 0001213900-24-013602 | 8414 | ||||||
| 2024-02-08 | 8-K | CURRENT REPORT | 1.01,3.02 | 0001213900-24-011587 | 001-34471 | 24608975 | 34 | 203210 | 1 | 1 |
| 2024-02-06 | CORRESP | filename1.htm | 0001213900-24-010564 | 13825 | ||||||
| 2024-02-06 | S-3/A | AMENDMENT NO. 1 TO FORM S-3 | 0001213900-24-010555 | 333-276481 | 24600481 | 33 | 566626 | |||
| 2024-01-26 | SC 13G | SCHEDULE 13G | 0001213900-24-007039 | 005-80735 | 24568797 | 34 | 51882 | |||
| 2024-01-26 | 3 | xslF345X02/ownership.xml | 0001213900-24-007038 | 3914 | ||||||
| 2024-01-25 | UPLOAD | filename1.pdf | 0000000000-24-001007 | 333-276481 | 45815 | |||||
| 2024-01-12 | S-3 | REGISTRATION STATEMENT | 0001213900-24-003333 | 333-276481 | 24532092 | 33 | 512342 | |||
| 2024-01-12 | SC 13G/A | NONE | 0001567619-24-000010 | 005-80735 | 24531744 | 34 | 99621 | |||
| 2023-12-21 | 8-K | CURRENT REPORT | 1.01,3.02 | 0001213900-23-097680 | 001-34471 | 231505328 | 34 | 200716 | 1 | 1 |
| 2023-12-19 | 8-K | CURRENT REPORT | 5.07,8.01 | 0001213900-23-096920 | 001-34471 | 231497286 | 34 | 210478 | 1 | 1 |
| 2023-11-16 | UPLOAD | filename1.pdf | 0000000000-23-012600 | 40037 | ||||||
| 2023-11-13 | 10-Q | QUARTERLY REPORT | 0001213900-23-086100 | 001-34471 | 231398618 | 34 | 4534305 | 1 | 1 | |
| 2023-11-09 | CORRESP | filename1.htm | 0001213900-23-085404 | 18943 | ||||||
| 2023-11-07 | DEF 14A | DEFINITIVE PROXY STATEMENT | 0001213900-23-084279 | 001-34471 | 231383644 | 34 | 2495949 | |||
| 2023-10-27 | PRE 14A | PRELIMINARY PROXY STATEMENT | 0001013762-23-007280 | 001-34471 | 231355549 | 34 | 224957 | |||
| 2023-10-27 | UPLOAD | filename1.pdf | 0000000000-23-011807 | 44153 | ||||||
| 2023-10-19 | 4 | xslF345X05/ownership.xml | 0001013762-23-005114 | 5462 | ||||||
| 2023-10-18 | CORRESP | filename1.htm | 0001013762-23-004725 | 32950 | ||||||
| 2023-10-03 | 8-K | CURRENT REPORT | 3.01 | 0001013762-23-001101 | 001-34471 | 231303484 | 34 | 199334 | 1 | 1 |
| 2023-09-26 | UPLOAD | filename1.pdf | 0000000000-23-010596 | 51535 | ||||||
| 2023-09-08 | CORRESP | filename1.htm | 0001213900-23-075543 | 1095218 | ||||||
| 2023-08-14 | 10-Q | QUARTERLY REPORT | 0001213900-23-066936 | 001-34471 | 231169253 | 34 | 3730604 | 1 | 1 | |
| 2023-07-25 | UPLOAD | filename1.pdf | 0000000000-23-007961 | 59360 | ||||||
| 2023-05-12 | 10-Q | QUARTERLY REPORT | 0001213900-23-039007 | 001-34471 | 23915630 | 34 | 3648486 | 1 | 1 | |
| 2023-04-20 | 8-K | CURRENT REPORT | 1.01,9.01 | 0001213900-23-031309 | 001-34471 | 23833125 | 34 | 230648 | 1 | 1 |
| 2023-03-30 | 10-K | ANNUAL REPORT | 0001213900-23-024710 | 001-34471 | 23781449 | 34 | 7297652 | 1 | 1 | |
| 2023-03-29 | 8-K | CURRENT REPORT | 8.01 | 0001213900-23-024081 | 001-34471 | 23775232 | 34 | 202417 | 1 | 1 |
| 2023-03-09 | SC 13G | SCHEDULE 13G | 0001213900-23-018879 | 005-80735 | 23719746 | 34 | 50049 | |||
| 2023-03-09 | 3 | xslF345X02/ownership.xml | 0001213900-23-018875 | 3932 | ||||||
| 2023-02-24 | 8-K | CURRENT REPORT | 7.01,9.01 | 0001213900-23-014316 | 001-34471 | 23667013 | 34 | 210933 | 1 | 1 |
| 2022-12-30 | 8-K | CURRENT REPORT | 5.07 | 0001213900-22-084016 | 001-34471 | 221502020 | 34 | 209700 | 1 | 1 |
| 2022-12-05 | SC 13G/A | NONE | 0001567619-22-021265 | 005-80735 | 221444703 | 34 | 99543 | |||
| 2022-12-02 | 8-K | CURRENT REPORT | 1.01,3.02,9.01 | 0001213900-22-077369 | 001-34471 | 221442832 | 34 | 243755 | 1 | 1 |
| 2022-12-02 | 8-K | CURRENT REPORT | 3.01,9.01 | 0001213900-22-077304 | 001-34471 | 221442039 | 34 | 228695 | 1 | 1 |
| 2022-11-14 | DEF 14A | DEFINITIVE PROXY STATEMENT | 0001213900-22-072361 | 001-34471 | 221387124 | 34 | 485883 | |||
| 2022-11-14 | 10-Q | QUARTERLY REPORT | 0001213900-22-072200 | 001-34471 | 221385246 | 34 | 3636366 | 1 | 1 | |
| 2022-11-04 | PRE 14A | PRELIMINARY PROXY STATEMENT | 0001213900-22-069418 | 001-34471 | 221362756 | 34 | 414081 | |||
| 2022-10-24 | S-8 | REGISTRATION STATEMENT | 0001213900-22-065840 | 333-267989 | 221326246 | 33 | 189142 | |||
| 2022-09-30 | 8-K | CURRENT REPORT | 3.01,9.01 | 0001213900-22-060675 | 001-34471 | 221284212 | 34 | 220007 | 1 | 1 |
| 2022-09-27 | SC 13G | NONE | 0001567619-22-017840 | 005-80735 | 221270881 | 34 | 99546 | |||
| 2022-08-11 | 10-Q | QUARTERLY REPORT | 0001213900-22-046859 | 001-34471 | 221155664 | 34 | 3477590 | 1 | 1 | |
| 2022-06-22 | 8-K | CURRENT REPORT | 3.01,9.01 | 0001213900-22-034328 | 001-34471 | 221032056 | 34 | 220468 | 1 | 1 |
| 2022-05-12 | 10-Q | QUARTERLY REPORT | 0001213900-22-025938 | 001-34471 | 22917788 | 34 | 3278379 | 1 | 1 | |
| 2022-03-30 | 10-K | ANNUAL REPORT | 0001213900-22-016151 | 001-34471 | 22786455 | 34 | 4904614 | 1 | 1 | |
| 2021-12-29 | 8-K | CURRENT REPORT | 5.07 | 0001213900-21-067912 | 001-34471 | 211528810 | 34 | 204502 | 1 | 1 |
| 2021-12-16 | 424B5 | PROSPECTUS SUPPLEMENT | 0001213900-21-065682 | 333-251973 | 211497856 | 33 | 364327 | |||
| 2021-11-29 | D | xslFormDX01/primary_doc.xml | 06b | 0001213900-21-062343 | 021-422728 | 211456110 | 33 | 9325 | ||
| 2021-11-23 | 8-K | CURRENT REPORT | 1.01,2.03,9.01 | 0001213900-21-061610 | 001-34471 | 211438914 | 34 | 485222 | 1 | 1 |
| 2021-11-15 | DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | 0001213900-21-059539 | 001-34471 | 211412418 | 34 | 130947 | |||
| 2021-11-15 | DEF 14A | DEFINITIVE PROXY STATEMENT | 0001213900-21-059533 | 001-34471 | 211412361 | 34 | 195976 | |||
| 2021-11-12 | 10-Q | QUARTERLY REPORT | 0001213900-21-058670 | 001-34471 | 211403406 | 34 | 3552164 | 1 | 1 | |
| 2021-09-15 | 8-K | CURRENT REPORT | 5.02,9.01 | 0001213900-21-048212 | 001-34471 | 211255467 | 34 | 227851 | 1 | 1 |
| 2021-09-13 | 4 | xslF345X03/ownership.xml | 0001213900-21-047830 | 5279 | ||||||
| 2021-08-13 | 10-Q | QUARTERLY REPORT | 0001213900-21-042474 | 001-34471 | 211172093 | 34 | 3593958 | 1 | 1 | |
| 2021-05-14 | 10-Q | QUARTERLY REPORT | 0001213900-21-026413 | 001-34471 | 21924628 | 34 | 2333627 | 1 | ||
| 2021-03-26 | 10-K | ANNUAL REPORT | 0001213900-21-017981 | 001-34471 | 21777327 | 34 | 3793993 | 1 | ||
| 2021-01-21 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2021-01-21 16:00:00 | 9999999995-21-000225 | 333-251973 | 21543658 | 33 | 2032 | ||
| 2021-01-19 | CORRESP | filename1.htm | 0001213900-21-002702 | 7827 | ||||||
| 2021-01-15 | UPLOAD | filename1.pdf | 0000000000-21-000525 | 40556 | ||||||
| 2021-01-08 | S-3 | REGISTRATION STATEMENT | 0001213900-21-001190 | 333-251973 | 21517723 | 33 | 592722 | |||
| 2021-01-08 | 4 | OWNERSHIP DOCUMENT | 0001213900-21-001170 | 5304 | ||||||
| 2020-12-29 | 8-K | CURRENT REPORT | 5.02,5.07 | 0001213900-20-045181 | 001-34471 | 201422457 | 34 | 21482 | ||
| 2020-12-21 | S-8 | REGISTRATION STATEMENT | 0001213900-20-043823 | 333-251545 | 201404693 | 33 | 121072 | |||
| 2020-11-16 | DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | 0001213900-20-037362 | 001-34471 | 201316949 | 34 | 98018 | |||
| 2020-11-16 | DEF 14A | DEFINITIVE PROXY STATEMENT | 0001213900-20-037345 | 001-34471 | 201316788 | 34 | 143638 | |||
| 2020-11-13 | 10-Q | QUARTERLY REPORT | 0001213900-20-036919 | 001-34471 | 201311461 | 34 | 2933597 | 1 | ||
| 2020-08-13 | 10-Q | QUARTERLY REPORT | 0001213900-20-021867 | 001-34471 | 201099355 | 34 | 2439498 | 1 | ||
| 2020-05-14 | 10-Q | QUARTERLY REPORT | 0001213900-20-012258 | 001-34471 | 20877770 | 34 | 2343941 | 1 | ||
| 2020-03-30 | 10-K | ANNUAL REPORT | 0001213900-20-008020 | 001-34471 | 20757755 | 34 | 3667166 | 1 | ||
| 2019-12-23 | 8-K | CURRENT REPORT | 5.07 | 0001213900-19-026825 | 001-34471 | 191306001 | 34 | 22985 | ||
| 2019-11-14 | 10-Q | QUARTERLY REPORT | 0001213900-19-023467 | 001-34471 | 191220004 | 34 | 2406885 | 1 | ||
| 2019-11-06 | DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | 0001213900-19-022243 | 001-34471 | 191197381 | 34 | 91690 | |||
| 2019-11-06 | DEF 14A | DEFINITIVE PROXY STATEMENT | 0001213900-19-022241 | 001-34471 | 191197366 | 34 | 215795 | |||
| 2019-08-14 | 10-Q | QUARTERLY REPORT | 0001213900-19-015792 | 001-34471 | 191026279 | 34 | 2585239 | 1 | ||
| 2019-05-14 | 10-Q | QUARTERLY REPORT | 0001213900-19-008566 | 001-34471 | 19822850 | 34 | 2287465 | 1 | ||
| 2019-03-28 | 10-K | ANNUAL REPORT | 0001213900-19-005094 | 001-34471 | 19711929 | 34 | 3043774 | 1 | ||
| 2018-12-06 | 8-K | CURRENT REPORT | 5.07 | 0001213900-18-017006 | 001-34471 | 181220699 | 34 | 19238 | ||
| 2018-11-14 | 10-Q | QUARTERLY REPORT | 0001213900-18-015783 | 001-34471 | 181183722 | 34 | 2073701 | 1 | ||
| 2018-10-25 | DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | 0001213900-18-014461 | 001-34471 | 181138616 | 34 | 120532 | |||
| 2018-10-25 | DEF 14A | DEFINITIVE PROXY STATEMENT | 0001213900-18-014459 | 001-34471 | 181138582 | 34 | 292945 | |||
| 2018-08-14 | 10-Q | QUARTERLY REPORT | 0001213900-18-010992 | 001-34471 | 181017226 | 34 | 2098549 | 1 | ||
| 2018-05-14 | 10-Q | QUARTERLY REPORT | 0001213900-18-006100 | 001-34471 | 18830509 | 34 | 1955074 | 1 | ||
| 2018-04-02 | 10-K | ANNUAL REPORT | 0001213900-18-003895 | 001-34471 | 18729731 | 34 | 3027915 | 1 | ||
| 2018-03-12 | 8-K | CURRENT REPORT | 8.01 | 0001213900-18-002824 | 001-34471 | 18683418 | 34 | 24178 | ||
| 2017-12-18 | 8-K | CURRENT REPORT | 5.07 | 0001213900-17-013370 | 001-34471 | 171261425 | 34 | 25883 | ||
| 2017-11-14 | 10-Q | QUARTERLY REPORT | 0001213900-17-012067 | 001-34471 | 171201277 | 34 | 2244355 | 1 | ||
| 2017-11-03 | DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | 0001213900-17-011354 | 001-34471 | 171177314 | 34 | 129303 | |||
| 2017-11-03 | DEF 14A | DEFINITIVE PROXY STATEMENT | 0001213900-17-011352 | 001-34471 | 171177274 | 34 | 242737 | |||
| 2017-09-12 | 8-K | CURRENT REPORT | 3.01,9.01 | 0001213900-17-009599 | 001-34471 | 171081209 | 34 | 25123 | ||
| 2017-08-14 | 10-Q | QUARTERLY REPORT | 0001213900-17-008653 | 001-34471 | 171030195 | 34 | 2317867 | 1 | ||
| 2017-05-11 | 10-Q | cphi10q033117.htm | 0001010549-17-000167 | 001-34471 | 17835258 | 34 | 2200535 | 1 | ||
| 2017-03-31 | 10-K | cphi10k123116.htm | 0001010549-17-000112 | 001-34471 | 17730661 | 34 | 3040498 | 1 | ||
| 2017-03-31 | 8-K | cphi8k033017.htm | 2.02,9.01 | 0001213900-17-003047 | 001-34471 | 17727821 | 34 | 155386 | ||
| 2016-12-28 | 8-K | cphi8k122716.htm | 8.01 | 0001010549-16-000877 | 001-34471 | 162072677 | 34 | 16009 | ||
| 2016-12-13 | 8-K | cphi8k121316.htm | 5.07 | 0001010549-16-000864 | 001-34471 | 162048978 | 34 | 36661 | ||
| 2016-12-02 | 8-K | cphi8k120116.htm | 4.01,9.01 | 0001010549-16-000834 | 001-34471 | 162031268 | 34 | 151751 | ||
| 2016-11-14 | 10-Q | cphi10q093016.htm | 0001010549-16-000787 | 001-34471 | 161994843 | 34 | 3078630 | 1 | ||
| 2016-10-28 | DEFA14A | cphidefa14a102816.htm | 0001010549-16-000757 | 001-34471 | 161958538 | 34 | 975046 | |||
| 2016-10-28 | DEF 14A | cphi14a102816.htm | 0001010549-16-000755 | 001-34471 | 161958516 | 34 | 249458 | |||
| 2016-08-11 | 10-Q | cphi10q063016.htm | 0001010549-16-000678 | 001-34471 | 161824927 | 34 | 3149768 | 1 | ||
| 2016-05-16 | 10-Q | cphi10q033116.htm | 0001010549-16-000606 | 001-34471 | 161654538 | 34 | 2628188 | 1 | ||
| 2016-03-30 | 10-K | cphi10k123115.htm | 0001010549-16-000541 | 001-34471 | 161539752 | 34 | 13614351 | 1 | ||
| 2015-12-28 | 10-Q/A | CHINA PHARMA | 0001010549-15-000422 | 001-34471 | 151307957 | 34 | 3827374 | 1 | ||
| 2015-12-28 | 10-Q/A | CHINA PHARMA | 0001010549-15-000420 | 001-34471 | 151307955 | 34 | 3769936 | 1 | ||
| 2015-12-28 | 10-Q/A | CHINA PHARMA | 0001010549-15-000418 | 001-34471 | 151307953 | 34 | 3367078 | 1 | ||
| 2015-12-28 | 10-K/A | CHINA PHARMA | 0001010549-15-000416 | 001-34471 | 151307948 | 34 | 5321458 | 1 | ||
| 2015-12-11 | 8-K | CHINA PHARMA | 4.02,9.01 | 0001010549-15-000389 | 001-34471 | 151283322 | 34 | 35437 | ||
| 2015-12-10 | 8-K | CHINA PHARMA | 5.07 | 0001010549-15-000387 | 001-34471 | 151280929 | 34 | 41293 | ||
| 2015-11-16 | 10-Q | CHINA PHARMA | 0001010549-15-000343 | 001-34471 | 151234508 | 34 | 3156330 | 1 | ||
| 2015-10-29 | DEFA14A | CHINA PHARMA | 0001010549-15-000314 | 001-34471 | 151181229 | 34 | 420397 | |||
| 2015-10-29 | DEF 14A | CHINA PHARMA | 0001010549-15-000313 | 001-34471 | 151181227 | 34 | 278321 | |||
| 2015-08-14 | 10-Q | CHINA PHARMA | 0001010549-15-000256 | 001-34471 | 151052863 | 34 | 3073037 | 1 | ||
| 2015-05-11 | 10-Q | CHINA PHARMA | 0001010549-15-000168 | 001-34471 | 15850685 | 34 | 3703898 | 1 | ||
| 2015-03-30 | 10-K | CHINA PHARMA | 0001010549-15-000090 | 001-34471 | 15734474 | 34 | 6032305 | 1 | ||
| 2014-12-31 | 8-K | CHINA PHARMA | 5.07 | 0001010549-14-000673 | 001-34471 | 141318354 | 34 | 23376 | ||
| 2014-11-21 | DEFA14C | CHINA PHARMA HOLDINGS | 0001010549-14-000635 | 001-34471 | 141240123 | 34 | 465597 | |||
| 2014-11-20 | DEF 14A | CHINA PHARMA HOLDINGS | 0001010549-14-000633 | 001-34471 | 141240114 | 34 | 256343 | |||
| 2014-11-14 | 10-Q | CHINA PHARMA HOLDINGS | 0001010549-14-000619 | 001-34471 | 141224046 | 34 | 3994625 | 1 | ||
| 2014-08-14 | 10-Q | CHINA PHARMA HOLDINGS | 0001010549-14-000422 | 001-34471 | 141042690 | 34 | 2930283 | 1 | ||
| 2014-05-15 | 10-Q | CHINA PHARMA HOLDINGS | 0001010549-14-000242 | 001-34471 | 14844203 | 34 | 3587264 | 1 | ||
| 2014-03-20 | 10-K | CHINA PHARMA HOLDINGS, INC. | 0001010549-14-000114 | 001-34471 | 14706884 | 34 | 6623324 | 1 | ||
| 2013-12-17 | 8-K | CHINA PHARMA HOLDINGS | 5.07 | 0001010549-13-000745 | 001-34471 | 131282025 | 34 | 24365 | ||
| 2013-11-14 | 10-Q | CHINA PHARMA HOLDINGS | 0001010549-13-000676 | 001-34471 | 131220532 | 34 | 4359532 | 1 | ||
| 2013-11-06 | DEFA14A | CHINA PHARMA HOLDINGS | 0001010549-13-000626 | 001-34471 | 131196860 | 34 | 367661 | |||
| 2013-11-06 | DEF 14A | CHINA PHARMA HOLDINGS, INC. | 0001010549-13-000624 | 001-34471 | 131196841 | 34 | 302865 | |||
| 2013-10-15 | 8-K | CHINA PHARMA HOLDINGS, INC. | 4.01 | 0001010549-13-000594 | 001-34471 | 131150552 | 34 | 22795 | ||
| 2013-09-04 | 8-K | CHINA PHARMA HOLDINGS, INC. | 4.01,9.01 | 0001010549-13-000560 | 001-34471 | 131078072 | 34 | 52620 | ||
| 2013-08-14 | 10-Q | CHINA PHARMA HOLDINGS, INC. | 0001010549-13-000521 | 001-34471 | 131039288 | 34 | 5450365 | 1 | ||
| 2013-05-14 | 10-Q | CHINA PHARMA HOLDINGS | 0001010549-13-000329 | 001-34471 | 13842049 | 34 | 3107517 | 1 | ||
| 2013-03-14 | 10-K | CHINA PHARMA HOLDINGS, INC. | 0001010549-13-000144 | 001-34471 | 13690862 | 34 | 5599959 | 1 | ||
| 2013-02-14 | SC 13G | cphi13g021513.txt | 0001166134-13-000006 | 005-80735 | 13604946 | 34 | 17111 | |||
| 2013-02-12 | SC 13G/A | d1345452_13g-a.htm | 0000919574-13-000765 | 005-80735 | 13596401 | 34 | 231454 | |||
| 2013-01-04 | 8-K | CHINA PHARMA HOLDINGS, INC. | 1.01,3.03,9.01 | 0001010549-13-000005 | 001-34471 | 13512148 | 34 | 273975 | ||
| 2012-12-26 | 8-K | CHINA PHARMA HOLDINGS, INC. | 5.07 | 0001010549-12-001324 | 001-34471 | 121285396 | 34 | 31483 | ||
| 2012-11-19 | DEF 14A | CHINA PHARMA HOLDINGS, INC. | 0001010549-12-001246 | 001-34471 | 121214616 | 34 | 516270 | |||
| 2012-11-14 | 10-Q | CHINA PHARMA HOLDINGS, INC. | 0001010549-12-001213 | 001-34471 | 121204466 | 34 | 4070468 | 1 | ||
| 2012-11-09 | PRE 14A | CHINA PHARMA HOLDINGS, INC. | 0001010549-12-001175 | 001-34471 | 121193508 | 34 | 516130 | |||
| 2012-08-14 | 10-Q | CHINA PHARMA HOLDINGS, INC | 0001010549-12-000896 | 001-34471 | 121032847 | 34 | 4054175 | 1 | ||
| 2012-05-14 | 10-Q | CHINA PHARMA HOLDINGS, INC | 0001010549-12-000533 | 001-34471 | 12839704 | 34 | 2024032 | 1 | ||
| 2012-05-01 | 4 | OWNERSHIP DOCUMENT | 0001010549-12-000445 | 11744 | ||||||
| 2012-04-30 | 8-K | CHINA PHARMA HOLDINGS, INC. | 5.02,9.01 | 0001010549-12-000438 | 001-34471 | 12795511 | 34 | 60343 | ||
| 2012-03-14 | 10-K | CHINA PHARMA HOLDINGS, INC. | 0001010549-12-000255 | 001-34471 | 12691062 | 34 | 4038282 | 1 | ||
| 2012-03-07 | UPLOAD | filename1.pdf | 0000000000-12-011860 | 48355 | ||||||
| 2012-03-06 | 10-Q/A | CHINA PHARMA HOLDINGS, INC. | 0001010549-12-000234 | 001-34471 | 12671546 | 34 | 2831247 | 1 | ||
| 2012-03-06 | CORRESP | filename1.htm | 0001010549-12-000232 | 42061 | ||||||
| 2012-03-02 | 8-K | CHINA PHARMA HOLDINGS, INC. | 4.02 | 0001010549-12-000215 | 001-34471 | 12663313 | 34 | 26666 | ||
| 2012-02-28 | CORRESP | filename1.htm | 0001010549-12-000205 | 166229 | ||||||
| 2012-02-15 | SC 13G | cphi13g021512.txt | 0001166134-12-000005 | 005-80735 | 12613466 | 34 | 16925 | |||
| 2012-02-14 | SC 13G/A | d1266273_13g-a.htm | 0000919574-12-001550 | 005-80735 | 12607841 | 34 | 202103 | |||
| 2012-02-13 | CORRESP | filename1.htm | 0001010549-12-000139 | 74642 | ||||||
| 2012-02-10 | SC 13G/A | cphi_2.txt | 0000937394-12-000076 | 005-80735 | 12592546 | 34 | 10432 | |||
| 2012-02-10 | SC 13G/A | cphi_1.txt | 0000937394-12-000016 | 005-80735 | 12590645 | 34 | 11331 | |||
| 2012-01-17 | CORRESP | filename1.htm | 0001010549-12-000055 | 97265 | ||||||
| 2011-12-30 | 8-K | g5686.htm | 5.07 | 0001165527-11-001254 | 001-34471 | 111288259 | 34 | 32519 | ||
| 2011-12-29 | CORRESP | filename1.htm | 0001165527-11-001248 | 13255 | ||||||
| 2011-12-16 | UPLOAD | filename1.pdf | 0000000000-11-072147 | 67637 | ||||||
| 2011-11-23 | DEFA14A | CHINA PHARMA HOLDINGS, INC. | 0001010549-11-001316 | 001-34471 | 111224318 | 34 | 609040 | |||
| 2011-11-17 | CORRESP | filename1.htm | 0001010549-11-001305 | 66626 | ||||||
| 2011-11-14 | DEF 14A | CHINA PHARMA HOLDINGS, INC. | 0001010549-11-001258 | 001-34471 | 111198176 | 34 | 307012 | |||
| 2011-11-10 | 10-Q | CHINA PHARMA HOLDINGS, INC. | 0001010549-11-001255 | 001-34471 | 111195745 | 34 | 2472909 | 1 | ||
| 2011-11-02 | UPLOAD | filename1.pdf | 0000000000-11-063928 | 60693 | ||||||
| 2011-10-24 | CORRESP | filename1.htm | 0001010549-11-001170 | 55878 | ||||||
| 2011-09-23 | CORRESP | filename1.htm | 0001010549-11-001081 | 13547 | ||||||
| 2011-09-13 | UPLOAD | filename1.pdf | 0000000000-11-054533 | 61237 | ||||||
| 2011-09-06 | 10-Q/A | CHINA PHARMA HOLDINGS, INC. | 0001010549-11-000997 | 001-34471 | 111076269 | 34 | 1778833 | 1 | ||
| 2011-08-19 | CORRESP | filename1.htm | 0001010549-11-000886 | 201254 | ||||||
| 2011-08-16 | CORRESP | filename1.htm | 0001010549-11-000858 | 12521 | ||||||
| 2011-08-10 | 10-Q | CHINA PHARMA HOLDINGS, INC. | 0001010549-11-000829 | 001-34471 | 111025157 | 34 | 1036138 | |||
| 2011-08-03 | CORRESP | filename1.htm | 0001010549-11-000788 | 11525 | ||||||
| 2011-07-25 | UPLOAD | filename1.pdf | 0000000000-11-044852 | 69014 | ||||||
| 2011-06-01 | 8-K | CHINA PHARMA HOLDINGS, INC,. | 5.02,9.01 | 0001010549-11-000554 | 001-34471 | 11884656 | 34 | 261147 | ||
| 2011-05-27 | 4 | ZHILIN LI | 0001010549-11-000528 | 8264 | ||||||
| 2011-05-27 | 4 | FRANK WAUNG | 0001010549-11-000526 | 8348 | ||||||
| 2011-05-10 | 10-Q | CHINA PHARMA HOLDINGS, INC. | 0001010549-11-000431 | 001-34471 | 11829277 | 34 | 571384 | |||
| 2011-03-17 | 10-K/A | CHINA PHARMA HOLDINGS, INC. | 0001010549-11-000249 | 001-34471 | 11695945 | 34 | 1679396 | |||
| 2011-03-15 | 10-Q/A | CHINA PHARMA HOLDINGS, INC. | 0001010549-11-000240 | 001-34471 | 11689521 | 34 | 1117308 | |||
| 2011-03-15 | 10-Q/A | CHINA PHARMA HOLDINGS, INC. | 0001010549-11-000238 | 001-34471 | 11689509 | 34 | 1066290 | |||
| 2011-03-15 | 10-Q/A | CHINA PHARMA HOLDINGS, INC. | 0001010549-11-000236 | 001-34471 | 11689486 | 34 | 844896 | |||
| 2011-03-03 | 10-K | CHINA PHARMA HOLDINGS, INC. | 0001010549-11-000201 | 001-34471 | 11658335 | 34 | 1819575 | |||
| 2011-03-02 | 4 | FORM 4 WUANG | 0001010549-11-000198 | 5322 | ||||||
| 2011-02-16 | SC 13G | cphi13g021511.txt | 0001166134-11-000013 | 005-80735 | 11615585 | 34 | 17347 | |||
| 2011-02-11 | SC 13G/A | d1168707_13g-a.htm | 0000919574-11-000820 | 005-80735 | 11598789 | 34 | 185211 | |||
| 2011-02-10 | SC 13G/A | cphi_.txt | 0000937394-11-000020 | 005-80735 | 11589777 | 34 | 11750 | |||
| 2010-12-29 | 8-K | CHINA PHARMA HOLDINGS, INC. | 5.07 | 0001010549-10-000840 | 001-34471 | 101277357 | 34 | 26579 | ||
| 2010-11-19 | 4 | PRIMARY DOCUMENT | 0001010549-10-000745 | 10748 | ||||||
| 2010-11-12 | DEFA14A | CHINA PHARMA HOLDINGS, INC. | 0001010549-10-000708 | 001-34471 | 101187898 | 34 | 374249 | |||
| 2010-11-12 | DEF 14A | CHINA PHARMA HOLDINGS, INC. | 0001010549-10-000706 | 001-34471 | 101187873 | 34 | 625014 | |||
| 2010-11-10 | 10-Q | CHINA PHARMA HOLDINGS, INC. | 0001010549-10-000688 | 001-34471 | 101180646 | 34 | 737738 | |||
| 2010-08-09 | 10-Q | CHINA PHARMA HOLDINGS, INC. | 0001010549-10-000470 | 001-34471 | 101001743 | 34 | 1171884 | |||
| 2010-05-10 | 10-Q | CHINA PHARMA HOLDINGS, INC. | 0001010549-10-000294 | 001-34471 | 10817495 | 34 | 494059 | |||
| 2010-05-05 | DEF 14C | CHINA PHARMA HOLDINGS, INC. | 0001010549-10-000280 | 001-34471 | 10802220 | 34 | 351268 | |||
| 2010-05-03 | UPLOAD | filename1.pdf | 0000000000-10-024061 | 12191 | ||||||
| 2010-04-30 | PRER14C | CHINA PHARMA HOLDINGS, INC. | 0001010549-10-000258 | 001-34471 | 10788119 | 34 | 431788 | |||
| 2010-04-26 | UPLOAD | filename1.pdf | 0000000000-10-022578 | 24901 | ||||||
| 2010-04-22 | CORRESP | filename1.htm | 0001010549-10-000243 | 139469 | ||||||
| 2010-04-22 | PRER14C | CHINA PHARMA HOLDINGS, INC. | 0001010549-10-000241 | 001-34471 | 10764988 | 34 | 324989 | |||
| 2010-04-07 | UPLOAD | filename1.pdf | 0000000000-10-018974 | 24359 | ||||||
| 2010-04-01 | PRE 14C | CHINA PHARMA HOLDINGS, INC. | 0001010549-10-000195 | 001-34471 | 10722633 | 34 | 107873 | |||
| 2010-03-04 | 10-K | cph10k123109.htm | 0001010549-10-000119 | 001-34471 | 10657537 | 34 | 1040147 | |||
| 2010-02-24 | EFFECT | xslEFFECTX01/primary_doc.xml | POS AM,0001010549-10-000048,2010-02-24 | 9999999995-10-000582 | 333-141734 | 10631436 | 33 | 2457 | ||
| 2010-02-16 | SC 13G/A | SCHEDULE 13G/A(2) -- CHINA PHARMA HOLDINGS, INC. | 0000919574-10-001335 | 005-80735 | 10604015 | 34 | 189686 | |||
| 2010-02-10 | 4 | xslF345X03/cph4tsui021010_ex.xml | 0001010549-10-000082 | 5038 | ||||||
| 2010-02-03 | POS AM | cphposam1020310.htm | 0001010549-10-000048 | 333-141734 | 10570967 | 33 | 326174 | |||
| 2010-01-15 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2010-01-15 12:00:00 | 9999999995-10-000236 | 333-164049 | 10531767 | 33 | 2444 | ||
| 2010-01-12 | CORRESP | filename1.htm | 0001010549-10-000018 | 18663 | ||||||
| 2010-01-12 | CORRESP | filename1.htm | 0001010549-10-000016 | 41056 | ||||||
| 2010-01-07 | UPLOAD | filename1.pdf | 0000000000-10-001317 | 35449 | ||||||
| 2009-12-28 | S-3 | cphs3122209.htm | 0001010549-09-000859 | 333-164049 | 091262399 | 33 | 1450481 | |||
| 2009-11-10 | 10-Q | cph10q093009.htm | 0001010549-09-000753 | 001-34471 | 091172317 | 34 | 343734 | |||
| 2009-10-19 | 3 | xslF345X02/cph3dong101909_ex.xml | 0001010549-09-000689 | 4349 | ||||||
| 2009-10-16 | 3 | PRIMARY DOCUMENT | 0001010549-09-000687 | 3630 | ||||||
| 2009-10-16 | 3 | PRIMARY DOCUMENT | 0001010549-09-000686 | 3640 | ||||||
| 2009-10-15 | 4 | PRIMARY DOCUMENT | 0001010549-09-000685 | 7990 | ||||||
| 2009-10-01 | 424B3 | cph424b3100109.htm | 0001010549-09-000671 | 333-152272 | 091097499 | 33 | 33837 | |||
| 2009-10-01 | 8-K | cph8k100109.htm | 8.01,9.01 | 0001010549-09-000669 | 001-34471 | 091097490 | 34 | 28883 | ||
| 2009-09-30 | 3 | xslF345X02/cph3waung093009_ex.xml | 0001010549-09-000665 | 4152 | ||||||
| 2009-09-29 | CERTNYS | AUTO-GENERATED PAPER DOCUMENT | 9999999997-09-025317 | 001-34471 | 09012368 | 34 | 2048 | |||
| 2009-09-28 | 424B3 | cph424b3092809.htm | 0001010549-09-000663 | 333-152272 | 091089483 | 33 | 91034 | |||
| 2009-09-28 | 8-A12B | cph812b092809.htm | 0001010549-09-000661 | 001-34471 | 091089476 | 34 | 21160 | |||
| 2009-09-23 | DEFR14C | cphdef14c092309.htm | 0001010549-09-000649 | 000-29523 | 091082132 | 34 | 223014 | |||
| 2009-09-23 | DEF 14C | cphdef14c092309.htm | 0001010549-09-000646 | 000-29523 | 091082096 | 34 | 223158 | |||
| 2009-09-15 | PRE 14C | cphpre14ca091509.htm | 0001010549-09-000626 | 000-29523 | 091069857 | 34 | 246757 | |||
| 2009-09-04 | 8-K | cph8k090409.htm | 5.02,9.01 | 0001010549-09-000622 | 000-29523 | 091055098 | 34 | 18285 | ||
| 2009-09-03 | PRE 14C | cphpre14c090309.htm | 0001010549-09-000620 | 000-29523 | 091052750 | 34 | 228573 | |||
| 2009-08-28 | 8-K | cph8k082809.htm | 8.01,9.01 | 0001010549-09-000614 | 000-29523 | 091041464 | 34 | 71032 | ||
| 2009-08-11 | 10-Q | cph10q063009.htm | 0001010549-09-000573 | 000-29523 | 091004005 | 34 | 299861 | |||
| 2009-07-23 | UPLOAD | filename1.pdf | 0000000000-09-039089 | 16213 | ||||||
| 2009-06-30 | 424B3 | cph424b3062909.htm | 0001010549-09-000469 | 333-152272 | 09918572 | 33 | 145130 | |||
| 2009-06-25 | DEF 14C | cphdef14c062509.htm | 0001010549-09-000463 | 000-29523 | 09908694 | 34 | 72252 | |||
| 2009-06-24 | CORRESP | filename1.htm | 0001010549-09-000461 | 27517 | ||||||
| 2009-06-24 | 10-Q/A | cph10qa033109.htm | 0001010549-09-000459 | 000-29523 | 09907622 | 34 | 62619 | |||
| 2009-06-24 | 10-K/A | cph10ka123108.htm | 0001010549-09-000457 | 000-29523 | 09907611 | 34 | 139979 | |||
| 2009-06-24 | 10-Q/A | cph10qa2093008.htm | 0001010549-09-000455 | 000-29523 | 09907597 | 34 | 63626 | |||
| 2009-06-24 | 10-Q/A | cph10qa2063008.htm | 0001010549-09-000453 | 000-29523 | 09907588 | 34 | 63973 | |||
| 2009-06-24 | 10-Q/A | cph10qa2033108.htm | 0001010549-09-000451 | 000-29523 | 09907581 | 34 | 63270 | |||
| 2009-06-24 | 10-K/A | cph10ka123107.htm | 0001010549-09-000449 | 000-29523 | 09907578 | 34 | 120340 | |||
| 2009-06-22 | PRE 14C | cphpre14c062209.htm | 0001010549-09-000445 | 000-29523 | 09902568 | 34 | 72285 | |||
| 2009-05-14 | 10-Q | cph10q033109.htm | 0001010549-09-000361 | 000-29523 | 09826751 | 34 | 303335 | |||
| 2009-05-04 | 424B3 | cph424b3050409.htm | 0001010549-09-000339 | 333-152272 | 09791771 | 33 | 42370 | |||
| 2009-04-30 | 8-K | cph8k043009.htm | 5.02,9.01 | 0001010549-09-000331 | 000-29523 | 09781445 | 34 | 32183 | ||
| 2009-03-27 | UPLOAD | filename1.pdf | 0000000000-09-015861 | 25451 | ||||||
| 2009-03-23 | 424B3 | cph424b3032309.htm | 0001010549-09-000186 | 333-152272 | 09698820 | 33 | 1197972 | |||
| 2009-03-17 | 10-K | cph10k123108.htm | 0001010549-09-000178 | 000-29523 | 09688982 | 34 | 1181214 | |||
| 2009-03-12 | CORRESP | filename1.txt | 0001010549-09-000166 | 8950 | ||||||
| 2009-03-12 | 10-Q/A | cph10qsba093008.txt | 0001010549-09-000164 | 000-29523 | 09674636 | 34 | 20444 | |||
| 2009-03-12 | 10-Q/A | cph10qsba063008.txt | 0001010549-09-000162 | 000-29523 | 09674632 | 34 | 23633 | |||
| 2009-03-12 | 10-Q/A | cph10qsba033108.txt | 0001010549-09-000160 | 000-29523 | 09674628 | 34 | 23271 | |||
| 2009-03-12 | 10KSB/A | cph10ksba123107.txt | 0001010549-09-000158 | 000-29523 | 09674620 | 34 | 35786 | |||
| 2009-02-13 | SC 13G/A | d962510_13g-a.txt | 0000919574-09-002538 | 005-80735 | 09600316 | 34 | 13348 | |||
| 2008-12-29 | 8-K | cph8k122908.txt | 3.02,9.01 | 0001010549-08-001044 | 000-29523 | 081271378 | 34 | 72132 | ||
| 2008-12-23 | UPLOAD | filename1.pdf | 0000000000-08-063448 | 39095 | ||||||
| 2008-11-06 | 10-Q | cph10q093008.txt | 0001010549-08-000871 | 000-29523 | 081168020 | 34 | 110418 | |||
| 2008-08-14 | 424B3 | cph424b081408.txt | 0001010549-08-000688 | 333-152272 | 081015650 | 33 | 267252 | |||
| 2008-08-12 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2008-08-12 09:00:00 | 9999999995-08-002542 | 333-152272 | 081011385 | 33 | 2445 | ||
| 2008-08-07 | CORRESP | filename1.txt | 0001010549-08-000635 | 3592 | ||||||
| 2008-08-05 | 10QSB | cph10q063008.txt | 0001010549-08-000625 | 000-29523 | 08991364 | 34 | 111377 | |||
| 2008-08-04 | CORRESP | filename1.txt | 0001010549-08-000619 | 3938 | ||||||
| 2008-07-29 | S-1/A | cphs1a072908.txt | 0001010549-08-000605 | 333-152272 | 08974824 | 33 | 298888 | |||
| 2008-07-15 | UPLOAD | filename1.pdf | 0000000000-08-034899 | 39413 | ||||||
| 2008-07-11 | DEF 14C | cphdef14c071108.txt | 0001010549-08-000564 | 000-29523 | 08948491 | 34 | 33918 | |||
| 2008-07-11 | S-1 | cphs1071108.txt | 0001010549-08-000562 | 333-152272 | 08948447 | 33 | 316721 | |||
| 2008-07-10 | UPLOAD | filename1.pdf | 0000000000-08-034161 | 19585 | ||||||
| 2008-07-10 | CORRESP | filename1.txt | 0001010549-08-000556 | 27923 | ||||||
| 2008-07-02 | UPLOAD | filename1.pdf | 0000000000-08-032781 | 33267 | ||||||
| 2008-06-27 | 8-K | cph8k062708.txt | 3.02,9.01 | 0001010549-08-000539 | 000-29523 | 08921108 | 34 | 114082 | ||
| 2008-06-27 | PRE 14C | cphpre14c062508.txt | 0001010549-08-000537 | 000-29523 | 08920770 | 34 | 73879 | |||
| 2008-06-09 | SC 13G | d890294_13g.txt | 0000919574-08-003630 | 005-80735 | 08888608 | 34 | 12711 | |||
| 2008-05-28 | 8-K | cphi8k052108.txt | 1.01,3.02,7.01,9.01 | 0001010549-08-000461 | 000-29523 | 08863618 | 34 | 262049 | ||
| 2008-04-30 | 10QSB | cph10qsb033108.txt | 0001010549-08-000323 | 000-29523 | 08790370 | 34 | 88041 | |||
| 2008-03-31 | 10KSB | cph10ksb123107.txt | 0001010549-08-000226 | 000-29523 | 08721712 | 34 | 237072 | |||
| 2008-02-28 | 8-K | cph8k022508.txt | 2.02,8.01,9.01 | 0001010549-08-000129 | 000-29523 | 08648623 | 34 | 10611 | ||
| 2008-02-04 | 8-K | cph8k020408.txt | 9.01 | 0001010549-08-000052 | 000-29523 | 08570724 | 34 | 8606 | ||
| 2007-11-14 | 10QSB | cph10qsb093007.txt | 0001010549-07-000941 | 000-29523 | 071241007 | 34 | 87312 | |||
| 2007-11-13 | SC 13D/A | cph13dyang111307.txt | 0001010549-07-000921 | 005-80735 | 071234952 | 34 | 13290 | |||
| 2007-11-13 | SC 13D/A | cph13dmei111307.txt | 0001010549-07-000919 | 005-80735 | 071234934 | 34 | 13657 | |||
| 2007-11-08 | 4 | xslF345X02/cph4tsui110707_ex.xml | 0001010549-07-000910 | 5094 | ||||||
| 2007-08-13 | 10QSB | chpha10qsb063007.txt | 0001010549-07-000644 | 000-29523 | 071050152 | 34 | 89429 | |||
| 2007-05-15 | 10QSB | cph10qsb033107.txt | 0001010549-07-000393 | 000-29523 | 07848079 | 34 | 74555 | |||
| 2007-05-08 | 424B3 | cph424b3050407.txt | 0001010549-07-000372 | 333-141734 | 07826450 | 33 | 244329 | |||
| 2007-05-04 | EFFECT | xslEFFECTX01/primary_doc.xml | SB-2,,2007-05-04 12:00:00 | 9999999995-07-001770 | 333-141734 | 07822163 | 33 | 2445 | ||
| 2007-05-03 | CORRESP | filename1.txt | 0001010549-07-000365 | 3892 | ||||||
| 2007-04-24 | SB-2/A | cphsb2a2033007.txt | 0001010549-07-000339 | 333-141734 | 07783772 | 33 | 267317 | |||
| 2007-04-17 | UPLOAD | filename1.pdf | 0000000000-07-018919 | 39007 | ||||||
| 2007-04-03 | SB-2/A | cphsb2a033007.txt | 0001010549-07-000288 | 333-141734 | 07742770 | 33 | 265894 | |||
| 2007-03-30 | SB-2 | cphsb2033007.txt | 0001010549-07-000271 | 333-141734 | 07734609 | 33 | 268386 | |||
| 2007-03-28 | 10KSB | cph10ksb123106.txt | 0001010549-07-000263 | 000-29523 | 07724463 | 34 | 250356 | |||
| 2007-02-14 | SC 13G/A | feb13ga-china_pharma.htm | 0000950138-07-000136 | 005-80735 | 07617815 | 34 | 92632 | |||
| 2007-02-06 | 8-K | cph8k020107.txt | 1.01,3.02,7.01,9.01 | 0001010549-07-000095 | 000-29523 | 07582710 | 34 | 101372 | ||
| 2006-11-13 | 10QSB | cph10qsb093006.txt | 0001010549-06-000742 | 000-29523 | 061209591 | 34 | 96594 | |||
| 2006-11-08 | 10KSB/A | cphi10ksba123105.txt | 0001010549-06-000730 | 000-29523 | 061196629 | 34 | 191471 | |||
| 2006-09-25 | SC 13D/A | cphisc13damei091306.txt | 0001010549-06-000642 | 005-80735 | 061105814 | 34 | 17867 | |||
| 2006-09-25 | SC 13D | cphisc13dli091306.txt | 0001010549-06-000641 | 005-80735 | 061105773 | 34 | 17570 | |||
| 2006-09-21 | 8-K | cph8k090606.txt | 2.02,9.01 | 0001010549-06-000635 | 000-29523 | 061102527 | 34 | 8011 | ||
| 2006-09-14 | 4 | xslF345X02/cphi4tsui091306_ex.xml | 0001010549-06-000620 | 5226 | ||||||
| 2006-09-14 | 4 | xslF345X02/cphi4li091306_ex.xml | 0001010549-06-000619 | 5259 | ||||||
| 2006-08-14 | 10QSB | cph10qsb063006.txt | 0001010549-06-000553 | 000-29523 | 061027162 | 34 | 66759 | |||
| 2006-05-16 | 4 | PRIMARY DOCUMENT | 0000899797-06-000189 | 5195 | ||||||
| 2006-05-15 | 10QSB | cphi10qsb033106.txt | 0001010549-06-000280 | 000-29523 | 06837398 | 34 | 62678 | |||
| 2006-05-04 | 8-K | FORM 8-K | 5.02,9.01 | 0000899797-06-000167 | 000-29523 | 06807034 | 34 | 21669 | ||
| 2006-03-31 | 10KSB | ts10ksb123105.txt | 0001010549-06-000169 | 000-29523 | 06726845 | 34 | 186979 | |||
| 2006-03-28 | DEF 14C | DEFINITIVE INFORMATION STATEMENT | 0000899797-06-000106 | 000-29523 | 06713535 | 34 | 61235 | |||
| 2006-03-16 | 424B3 | RULE 424(B)(3) | 0000899797-06-000098 | 333-129161 | 06690111 | 33 | 707145 | |||
| 2006-03-15 | PRER14C | SCHEDULE 14C - AMENDMENT NO. 1 | 0000899797-06-000094 | 000-29523 | 06687133 | 34 | 60469 | |||
| 2006-03-06 | SC 13D | SCHEDULE 13D | 0000899797-06-000075 | 005-80735 | 06666560 | 34 | 37222 | |||
| 2006-02-01 | CORRESP | filename1.htm | 0001204459-06-000094 | 6729 | ||||||
| 2006-01-25 | CORRESP | filename1.htm | 0001204459-06-000067 | 8292 | ||||||
| 2006-01-25 | PRE 14C | TS ELECTRONICS, INC. - SCHEDULE 14C | 0001204459-06-000066 | 000-29523 | 06548867 | 34 | 38671 | |||
| 2005-12-28 | 3 | xslF345X02/ts3li101905_ex.xml | 0001010549-05-000950 | 4222 | ||||||
| 2005-12-28 | 3 | xslF345X02/ts3yang101905_ex.xml | 0001010549-05-000949 | 4186 | ||||||
| 2005-12-28 | 3 | xslF345X02/ts3wu101905_ex.xml | 0001010549-05-000948 | 4208 | ||||||
| 2005-12-28 | 3 | xslF345X02/ts3tsui101905_ex.xml | 0001010549-05-000947 | 4175 | ||||||
| 2005-12-23 | SB-2/A | tssb2a2122205.txt | 0001010549-05-000945 | 333-129161 | 051284701 | 33 | 423457 | |||
| 2005-11-18 | 10QSB | ts10qsb093005.txt | 0001010549-05-000854 | 000-29523 | 051214640 | 34 | 74955 | |||
| 2005-11-16 | SB-2/A | tssb2a111405.txt | 0001010549-05-000846 | 333-129161 | 051209587 | 33 | 353050 | |||
| 2005-11-14 | NT 10-Q | ts12b2510q093005.txt | 0001010549-05-000824 | 000-29523 | 051199106 | 34 | 8348 | |||
| 2005-10-27 | SC 13G | SCHEDULE 13G | 0000950134-05-019859 | 005-80735 | 051159638 | 34 | 55546 | |||
| 2005-10-26 | UPLOAD | filename1.txt | 0000000000-05-054555 | 5671 | ||||||
| 2005-10-20 | SB-2 | tssb2101705.txt | 0001010549-05-000757 | 333-129161 | 051147981 | 33 | 390987 | |||
| 2005-10-20 | 8-K | ts8k101905.txt | 1.01,2.01,3.02,5.01 | 0001010549-05-000756 | 000-29523 | 051147972 | 34 | 402021 | ||
| 2005-10-04 | 3 | xslF345X02/ts3hfilp100405_ex.xml | 0001010549-05-000706 | 4220 | ||||||
| 2005-10-04 | 3 | xslF345X02/ts3brigante100405_ex.xml | 0001010549-05-000705 | 4585 | ||||||
| 2005-10-04 | 3 | xslF345X02/ts3diamond100405_ex.xml | 0001010549-05-000704 | 4559 | ||||||
| 2005-10-04 | 3 | xslF345X02/ts3rosenberg100405_ex.xml | 0001010549-05-000703 | 4500 | ||||||
| 2005-10-04 | 3 | xslF345X02/ts3halter100405_ex.xml | 0001010549-05-000702 | 4526 | ||||||
| 2005-10-04 | 3 | xslF345X02/hfillc3100405_ex.xml | 0001010549-05-000701 | 4527 | ||||||
| 2005-10-04 | 4 | xslF345X02/ts4halter100405_ex.xml | 0001010549-05-000699 | 7143 | ||||||
| 2005-10-04 | SC 13D | tssc13dhalter100405.txt | 0001010549-05-000698 | 005-80735 | 051122323 | 34 | 42165 | |||
| 2005-09-23 | 10KSB | ts10ksb063005.txt | 0001010549-05-000661 | 000-29523 | 051100802 | 34 | 102178 | |||
| 2005-08-23 | CORRESP | filename1.txt | 0001010549-05-000599 | 5061 | ||||||
| 2005-08-19 | UPLOAD | filename1.txt | 0000000000-05-042952 | 5584 | ||||||
| 2005-08-18 | 8-K | ts8k081705.txt | 4.01,9.01 | 0001010549-05-000587 | 000-29523 | 051035329 | 34 | 7173 | ||
| 2005-05-11 | SC 13D | tssc13dhalter051105.txt | 0001010549-05-000311 | 005-80735 | 05821633 | 34 | 45545 | |||
| 2005-05-11 | 3 | xslF345X02/ts3halter051105_ex.xml | 0001010549-05-000310 | 4427 | ||||||
| 2005-05-11 | 8-K | ts8k051105.txt | 3.02,5.01,5.02,9.01 | 0001010549-05-000309 | 000-29523 | 05821582 | 34 | 35395 | ||
| 2005-05-09 | 10QSB | tselectronic_10q-033105.txt | 0001019687-05-001291 | 000-29523 | 05812972 | 34 | 56197 | |||
| 2005-03-29 | 8-K | tselectronics_8k-011405.txt | 1.02,8.01 | 0001019687-05-000832 | 000-29523 | 05708870 | 34 | 6074 | ||
| 2005-02-22 | 10QSB | tselectronics_10q-123104.txt | 0001019687-05-000497 | 000-29523 | 05632188 | 34 | 58848 | |||
| 2005-02-14 | NT 10-Q | ts_ext.txt | 0001019687-05-000386 | 000-29523 | 05606231 | 34 | 8206 | |||
| 2004-11-24 | 10QSB | tselect_10q-093004.txt | 0001019687-04-002657 | 000-29523 | 041167037 | 34 | 58663 | |||
| 2004-11-15 | NT 10-Q | TS ELECTRONICS NT-10Q 9-30-04 | 0001060830-04-000381 | 000-29523 | 041143613 | 34 | 27564 | |||
| 2004-11-15 | NTN 10Q | TS ELECTRONICS, INC. NT-10Q 9-30-04 | 0001060830-04-000378 | 000-29523 | 041143493 | 34 | 27576 | |||
| 2004-10-14 | 10KSB | TS ELECTRONICS 10KSB 6-30-04 | 0001060830-04-000339 | 000-29523 | 041077697 | 34 | 802782 | |||
| 2004-10-04 | 8-K/A | TS ELECTRONICS 8K AMD 1 8-17-04 | 1.01 | 0001060830-04-000333 | 000-29523 | 041062792 | 306321 | |||
| 2004-09-27 | NT 10-K | TS ELECTRONICS, INC. NT 10K 6-30-04 | 0001060830-04-000329 | 000-29523 | 041047858 | 28358 | ||||
| 2004-08-20 | 8-K | TS ELECTRONICS 8K 8-17-04 | 1,2,7 | 0001060830-04-000308 | 000-29523 | 04989384 | 197819 | |||
| 2004-05-17 | 10QSB | tselectronics10qsb33104.txt | 0001060830-04-000148 | 000-29523 | 04812874 | 50209 | ||||
| 2004-03-25 | 10KSB/A | tselectronics10ksbamd2.txt | 0001060830-04-000065 | 000-29523 | 04690383 | 140906 | ||||
| 2004-03-09 | 8-K/A | tselectronics8kamd1.txt | 4,7 | 0001060830-04-000060 | 000-29523 | 04655672 | 13205 | |||
| 2004-02-18 | 10QSB | tselectronics10qsb123103.txt | 0001060830-04-000045 | 000-29523 | 04613178 | 50486 | ||||
| 2004-02-17 | NT 10-Q | tselectronics123103ext.txt | 0001060830-04-000032 | 000-29523 | 04606170 | 7763 | ||||
| 2004-02-06 | 8-K | tselectronics8k2404.txt | 4 | 0001060830-04-000022 | 000-29523 | 04572342 | 7655 | |||
| 2004-01-20 | AW | tselectronicsawsch13c.txt | 0001060830-04-000016 | 000-29523 | 04532415 | 3460 | ||||
| 2003-12-08 | 10KSB/A | tselectronics10ksbamd1.txt | 0001060830-03-000265 | 000-29523 | 031041736 | 131985 | ||||
| 2003-12-08 | PRER14C | tselectronicspre14camd2.txt | 0001060830-03-000262 | 000-29523 | 031041706 | 257357 | ||||
| 2003-11-19 | 10QSB | tselectronics10qsb93003.txt | 0001060830-03-000255 | 000-29523 | 031013709 | 132470 | ||||
| 2003-11-17 | NT 10-Q | tselectronics093003ext.txt | 0001060830-03-000234 | 000-29523 | 031007124 | 7765 | ||||
| 2003-10-14 | 10KSB | tselectronics10ksb63003.txt | 0001060830-03-000205 | 000-29523 | 03939667 | 122905 | ||||
| 2003-10-10 | PRER14C | tselectronicssch14camd1.txt | 0001060830-03-000204 | 000-29523 | 03936574 | 224587 | ||||
| 2003-10-09 | PRE 14C | tselectronicssch14camd1.txt | 0001060830-03-000203 | 000-29523 | 03935714 | 224624 | ||||
| 2003-09-25 | NT 10-K | tselectronics63003.txt | 0001060830-03-000199 | 000-29523 | 03909450 | 7750 | ||||
| 2003-08-29 | 10KSB/A | tselectronics10ksbamd3.txt | 0001060830-03-000188 | 000-29523 | 03872851 | 132631 | ||||
| 2003-08-20 | PRE 14C | tselectronic14c.txt | 0001060830-03-000176 | 000-29523 | 03858388 | 198963 |
One latest value per concept from companyfacts (430 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 43.02M | 2026-11-11 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 4.29M | 2025-06-30 | 2025 | FY | 10-K | 2026-04-01 | 0001213900-26-038521 | |
| us-gaap | AccountsAndOtherReceivablesNetCurrent | Accounts and Other Receivables, Net, Current | USD | 275,244 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-14 | 0001213900-23-066936 | |
| us-gaap | AccountsPayableAndAccruedLiabilitiesCurrent | Accounts Payable and Accrued Liabilities, Current | USD | 1.61M | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-14 | 0001213900-24-068984 | |
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 5.85M | 2012-03-31 | 2012 | Q1 | 10-Q | 2012-05-14 | 0001010549-12-000533 | |
| us-gaap | AccountsPayableOtherCurrent | Accounts Payable, Other, Current | USD | 2.57M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 | |
| us-gaap | AccountsPayableOtherCurrentAndNoncurrent | Accounts Payable, Other | USD | 375,351 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-14 | 0001213900-23-066936 | |
| us-gaap | AccountsPayableTradeCurrent | Accounts Payable, Trade, Current | USD | 304,494 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 | |
| us-gaap | AccountsReceivableGrossCurrent | Accounts Receivable, before Allowance for Credit Loss, Current | USD | 216,414 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 | |
| us-gaap | AccountsReceivableNet | Accounts Receivable, after Allowance for Credit Loss | USD | 11.35M | 2015-06-30 | 2015 | Q2 | 10-Q | 2015-12-28 | 0001010549-15-000420 | |
| us-gaap | AccountsReceivableNetCurrent | Accounts Receivable, after Allowance for Credit Loss, Current | USD | 196,588 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 | |
| us-gaap | AccretionAmortizationOfDiscountsAndPremiumsInvestments | Accretion (Amortization) of Discounts and Premiums, Investments | USD | -24,259 | 2023-01-01 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-14 | 0001213900-23-066936 |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 236,359 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 | |
| us-gaap | AccruedSalariesCurrent | Accrued Salaries, Current | USD | 1.26M | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-13 | 0001213900-24-097461 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 35.38M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | 13.04M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 77.88M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 | |
| us-gaap | AdjustmentForAmortization | Amortization | USD | 851,611 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-01 | 0001213900-26-038521 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition | USD | 36,270 | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0001213900-24-028731 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalWarrantIssued | Adjustments to Additional Paid in Capital, Warrant Issued | USD | 116,993 | 2010-01-01 | 2010-12-31 | 2011 | FY | 10-K | 2012-03-14 | 0001010549-12-000255 |
| us-gaap | AdvancesOnInventoryPurchases | Advances on Inventory Purchases | USD | 43.14M | 2015-06-30 | 2015 | Q2 | 10-Q | 2015-12-28 | 0001010549-15-000420 | |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 0 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-13 | 0001213900-24-097461 |
| us-gaap | AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables | Allowance for Doubtful Accounts, Premiums and Other Receivables | USD | 19,826 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 | |
| us-gaap | AllowanceForDoubtfulAccountsReceivable | Accounts Receivable, Allowance for Credit Loss | USD | 10,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-01 | 0001213900-26-038521 | |
| us-gaap | AllowanceForDoubtfulAccountsReceivableCurrent | Accounts Receivable, Allowance for Credit Loss, Current | USD | 19,826 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 | |
| us-gaap | AllowanceForDoubtfulAccountsReceivableWriteOffs | Accounts Receivable, Allowance for Credit Loss, Writeoff | USD | 2.67M | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0001213900-25-026280 |
| us-gaap | AllowanceForDoubtfulOtherReceivablesCurrent | Allowance for Doubtful Other Receivables, Current | USD | 27,978 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-14 | 0001213900-21-026413 | |
| us-gaap | AllowanceForNotesAndLoansReceivableCurrent | Financing Receivable, Allowance for Credit Loss, Current | USD | 39,806 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 | |
| us-gaap | AmortizationOfIntangibleAssets | Amortization of Intangible Assets | USD | 2.74M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 13,300 | 2025-01-01 | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-05-14 | 0001213900-25-043334 |
| us-gaap | AssetAcquisitionConsiderationTransferredOtherAssets | AssetAcquisitionConsiderationTransferredOtherAssets | USD | 65,639 | 2023-01-01 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-14 | 0001213900-23-066936 |
| us-gaap | AssetImpairmentCharges | Asset Impairment Charges | USD | 17.02M | 2019-01-01 | 2019-12-31 | 2020 | FY | 10-K | 2021-03-26 | 0001213900-21-017981 |
| us-gaap | Assets | Assets | USD | 46.93M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 5.39M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 | |
| us-gaap | AssetsFairValueDisclosure | Assets, Fair Value Disclosure | USD | 1,825 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-14 | 0001213900-26-090173 | |
| us-gaap | AssetsHeldInTrustCurrent | Assets Held-in-trust, Current | USD | 1,825 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-14 | 0001213900-26-090173 | |
| us-gaap | BankAcceptancesExecutedAndOutstanding | Bank Acceptances Executed and Outstanding | USD | 109,908 | 2019-12-31 | 2020 | FY | 10-K | 2021-03-26 | 0001213900-21-017981 | |
| us-gaap | BuildingsAndImprovementsGross | Buildings and Improvements, Gross | USD | 9.05M | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-14 | 0001213900-23-066936 | |
| us-gaap | CapitalExpendituresIncurredButNotYetPaid | Capital Expenditures Incurred but Not yet Paid | USD | 143,151 | 2011-01-01 | 2011-12-31 | 2011 | FY | 10-K | 2012-03-14 | 0001010549-12-000255 |
| us-gaap | CapitalLeaseObligations | Capital Lease Obligations | USD | 236,055 | 2018-12-31 | 2019 | Q1 | 10-Q | 2019-05-14 | 0001213900-19-008566 | |
| us-gaap | Cash | Cash | USD | 1.18M | 2021-09-09 | 2023 | FY | 10-K | 2024-04-01 | 0001213900-24-028731 | |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 3.68M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 | |
| us-gaap | CashAndCashEquivalentsPeriodIncreaseDecrease | Cash and Cash Equivalents, Period Increase (Decrease) | USD | -424,981 | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-14 | 0001213900-19-023467 |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 3.68M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | 3.33M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 |
| us-gaap | CashEquivalentsAtCarryingValue | Cash Equivalents, at Carrying Value | USD | 458,233 | 2014-12-31 | 2014 | FY | 10-K | 2015-12-28 | 0001010549-15-000416 | |
| us-gaap | CommonStockCapitalSharesReservedForFutureIssuance | Common Stock, Capital Shares Reserved for Future Issuance | shares | 10,000 | 2022-12-27 | 2025 | Q3 | 10-Q | 2025-11-12 | 0001213900-25-109203 | |
| us-gaap | CommonStockDividendsShares | Common Stock Dividends, Shares | shares | 3.00M | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-13 | 0001213900-24-097461 |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0.001 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 500.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 43.02M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 43.02M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 | |
| us-gaap | CommonStocksIncludingAdditionalPaidInCapital | Common Stocks, Including Additional Paid in Capital | USD | 90,000 | 2022-10-03 | 2022 | FY | 10-K | 2023-03-30 | 0001213900-23-024710 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 43,022 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 | |
| us-gaap | CommonUnitIssued | Common Unit, Issued | shares | 18,000 | 2022-10-03 | 2023 | FY | 10-K | 2024-04-01 | 0001213900-24-028731 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -3.05M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 |
| us-gaap | ConstructionInProgressGross | Construction in Progress, Gross | USD | 0 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-30 | 0001010549-16-000541 | |
| us-gaap | ConstructionLoan | Construction Loan | CNY | 3.80M | 2022-12-30 | 2023 | Q2 | 10-Q | 2023-08-14 | 0001213900-23-066936 | |
| us-gaap | ConstructionLoanNoncurrent | Long-term Construction Loan, Noncurrent | USD | 2.15M | 2019-12-31 | 2020 | FY | 10-K | 2021-03-26 | 0001213900-21-017981 | |
| us-gaap | ContractWithCustomerAssetAccumulatedAllowanceForCreditLossCurrent | Contract with Customer, Asset, Allowance for Credit Loss, Current | USD | 4,029 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-01 | 0001213900-26-038521 | |
| us-gaap | ContractWithCustomerLiabilityCurrent | Contract with Customer, Liability, Current | USD | 48,264 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 | |
| us-gaap | ConversionOfStockAmountIssued1 | Conversion of Stock, Amount Issued | USD | 1.85M | 2023-01-01 | 2023-09-30 | 2024 | Q3 | 10-Q | 2024-11-13 | 0001213900-24-097461 |
| us-gaap | ConversionOfStockSharesIssued1 | Conversion of Stock, Shares Issued | shares | 3.00M | 2023-12-15 | 2023 | FY | 10-K | 2024-04-01 | 0001213900-24-028731 | |
| us-gaap | ConvertibleLongTermNotesPayable | Convertible Notes Payable, Noncurrent | USD | 5.25M | 2021-12-31 | 2022 | FY | 10-K | 2023-03-30 | 0001213900-23-024710 | |
| us-gaap | ConvertibleNotesPayable | Convertible Notes Payable | USD | 5.25M | 2021-11-17 | 2022 | FY | 10-K | 2023-03-30 | 0001213900-23-024710 | |
| us-gaap | ConvertibleNotesPayableCurrent | Convertible Notes Payable, Current | USD | 940,000 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0001213900-25-026280 | |
| us-gaap | ConvertiblePreferredDividendsNetOfTax | Convertible Preferred Dividends, Net of Tax | USD | 4.55M | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-14 | 0001213900-22-072200 |
| us-gaap | CostOfRevenue | Cost of Revenue | USD | 2.62M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 |
| us-gaap | CurrentFederalTaxExpenseBenefit | Current Federal Tax Expense (Benefit) | USD | 0 | 2017-01-01 | 2017-03-31 | 2017 | Q1 | 10-Q | 2017-05-11 | 0001010549-17-000167 |
| us-gaap | CurrentIncomeTaxExpenseBenefit | Current Income Tax Expense (Benefit) | USD | -178,408 | 2018-01-01 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-30 | 0001213900-20-008020 |
| us-gaap | CustomerAdvancesAndDeposits | Customer Advances and Deposits | USD | 8.45M | 2015-06-30 | 2015 | Q2 | 10-Q | 2015-12-28 | 0001010549-15-000420 | |
| us-gaap | CustomerAdvancesCurrent | Customer Advances, Current | USD | 1.94M | 2020-03-31 | 2020 | Q1 | 10-Q | 2020-05-14 | 0001213900-20-012258 | |
| us-gaap | CustomersLiabilityForAcceptancesNet | Customer's Liability for Acceptances, Net | USD | 80,406 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-14 | 0001213900-23-066936 | |
| us-gaap | DebtInstrumentConvertibleConversionPrice1 | Debt Instrument, Convertible, Conversion Price | USD/shares | 0.285 | 2023-06-23 | 2023 | Q2 | 10-Q | 2023-08-14 | 0001213900-23-066936 | |
| us-gaap | DebtInstrumentConvertibleNumberOfEquityInstruments | Debt Instrument, Convertible, Number of Equity Instruments | pure | 350,000 | 2022-04-19 | 2023 | Q2 | 10-Q | 2023-08-14 | 0001213900-23-066936 | |
| us-gaap | DebtInstrumentFaceAmount | Debt Instrument, Face Amount | CNY | 15.00M | 2021-12-31 | 2022 | FY | 10-K | 2023-03-30 | 0001213900-23-024710 | |
| us-gaap | DebtInstrumentFeeAmount | Debt Instrument, Fee Amount | USD | 65,639 | 2023-04-13 | 2024 | Q3 | 10-Q | 2024-11-13 | 0001213900-24-097461 | |
| us-gaap | DebtInstrumentInterestRateEffectivePercentage | Debt Instrument, Interest Rate, Effective Percentage | pure | 0.039 | 2023-03-31 | 2023 | Q2 | 10-Q | 2023-08-14 | 0001213900-23-066936 | |
| us-gaap | DebtInstrumentInterestRateStatedPercentage | Debt Instrument, Interest Rate, Stated Percentage | pure | 0.033 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-01 | 0001213900-26-038521 | |
| us-gaap | DebtInstrumentPeriodicPayment | Debt Instrument, Periodic Payment | USD | 2.00M | 2013-06-01 | 2013-06-21 | 2020 | Q3 | 10-Q | 2020-11-13 | 0001213900-20-036919 |
| us-gaap | DebtInstrumentRedemptionPricePercentage | Debt Instrument, Redemption Price, Percentage | pure | 0.82 | 2024-12-09 | 2025 | FY | 10-K | 2026-04-01 | 0001213900-26-038521 | |
| us-gaap | DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed | Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed | pure | 0.82 | 2023-01-01 | 2023-09-30 | 2024 | Q3 | 10-Q | 2024-11-13 | 0001213900-24-097461 |
| us-gaap | DebtInstrumentRepurchaseAmount | Debt Instrument, Repurchase Amount | USD | 100,000 | 2024-09-11 | 2024 | Q3 | 10-Q | 2024-11-13 | 0001213900-24-097461 | |
| us-gaap | DebtWeightedAverageInterestRate | Debt, Weighted Average Interest Rate | pure | 0.82 | 2023-06-23 | 2023 | Q2 | 10-Q | 2023-08-14 | 0001213900-23-066936 | |
| us-gaap | DeferredFederalIncomeTaxExpenseBenefit | Deferred Federal Income Tax Expense (Benefit) | USD | 77,042 | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-12-28 | 0001010549-15-000416 |
| us-gaap | DeferredForeignIncomeTaxExpenseBenefit | Deferred Foreign Income Tax Expense (Benefit) | USD | 30,334 | 2017-01-01 | 2017-03-31 | 2017 | Q1 | 10-Q | 2017-05-11 | 0001010549-17-000167 |
| us-gaap | DeferredIncomeTaxAssetsNet | Deferred Income Tax Assets, Net | USD | 0 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-30 | 0001010549-16-000541 | |
| us-gaap | DeferredIncomeTaxesAndTaxCredits | Deferred Income Taxes and Tax Credits | USD | 111,910 | 2018-01-01 | 2018-09-30 | 2019 | Q3 | 10-Q | 2019-11-14 | 0001213900-19-023467 |
| us-gaap | DeferredIncomeTaxExpenseBenefit | Deferred Income Tax Expense (Benefit) | USD | 68,419 | 2018-01-01 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-30 | 0001213900-20-008020 |
| us-gaap | DeferredIncomeTaxLiabilitiesNet | Deferred Income Tax Liabilities, Net | USD | 780,415 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 | |
| us-gaap | DeferredRentCreditCurrent | Deferred Rent Credit, Current | USD | -16,581 | 2014-03-31 | 2014 | Q1 | 10-Q | 2014-05-15 | 0001010549-14-000242 | |
| us-gaap | DeferredRevenue | Deferred Revenue | USD | 172,357 | 2016-09-30 | 2016 | Q3 | 10-Q | 2016-11-14 | 0001010549-16-000787 | |
| us-gaap | DeferredRevenueAdditions | Deferred Revenue, Additions | USD | 2.51M | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-12-28 | 0001010549-15-000416 |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 21.21M | 2025-12-31 | 2025 | FY | 10-K | 2026-04-01 | 0001213900-26-038521 | |
| us-gaap | DeferredTaxAssetsGrossNoncurrent | Deferred Tax Assets, Gross, Noncurrent | USD | 274,157 | 2011-09-30 | 2011 | Q3 | 10-Q | 2011-11-10 | 0001010549-11-001255 | |
| us-gaap | DeferredTaxAssetsInventory | Deferred Tax Assets, Inventory | USD | 286,310 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-01 | 0001213900-26-038521 | |
| us-gaap | DeferredTaxAssetsLiabilitiesNet | Deferred Tax Assets, Net | USD | 6.45M | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-11-14 | 0001010549-14-000619 | |
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 23.20M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 | |
| us-gaap | DeferredTaxAssetsNetCurrent | Deferred Tax Assets, Net of Valuation Allowance, Current | USD | 0 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-20 | 0001010549-14-000114 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 2.08M | 2023-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0001213900-24-028731 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwardsDomestic | Deferred Tax Assets, Operating Loss Carryforwards, Domestic | USD | 2.46M | 2025-12-31 | 2025 | FY | 10-K | 2026-04-01 | 0001213900-26-038521 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwardsForeign | Deferred Tax Assets, Operating Loss Carryforwards, Foreign | USD | 7.68M | 2025-12-31 | 2025 | FY | 10-K | 2026-04-01 | 0001213900-26-038521 | |
| us-gaap | DeferredTaxAssetsOther | Deferred Tax Assets, Other | USD | 337 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-01 | 0001213900-26-038521 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwards | Deferred Tax Assets, Tax Credit Carryforwards | USD | 5.28M | 2023-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0001213900-24-028731 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | USD | 3,201 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-01 | 0001213900-26-038521 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseOther | Deferred Tax Assets, Tax Deferred Expense, Other | USD | 1.08M | 2025-12-31 | 2025 | FY | 10-K | 2026-04-01 | 0001213900-26-038521 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Allowance for Doubtful Accounts | USD | 3,256 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-01 | 0001213900-26-038521 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Impairment Losses | USD | 9.69M | 2025-12-31 | 2025 | FY | 10-K | 2026-04-01 | 0001213900-26-038521 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other | USD | 8,038 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-01 | 0001213900-26-038521 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsProvisionForLoanLosses | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Provision for Loan Losses | USD | 6,754 | 2023-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0001213900-24-028731 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 21.21M | 2025-12-31 | 2025 | FY | 10-K | 2026-04-01 | 0001213900-26-038521 | |
| us-gaap | DeferredTaxLiabilities | Deferred Tax Liabilities, Net | USD | 791,067 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-14 | 0001213900-18-006100 | |
| us-gaap | DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets | Deferred Tax Liabilities, Intangible Assets | USD | 747,805 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-01 | 0001213900-26-038521 | |
| us-gaap | DeferredTaxLiabilitiesNoncurrent | Deferred Tax Liabilities, Net, Noncurrent | USD | 741,863 | 2020-03-31 | 2020 | Q1 | 10-Q | 2020-05-14 | 0001213900-20-012258 | |
| us-gaap | DefinedBenefitPlanAccumulatedBenefitObligation | Defined Benefit Plan, Accumulated Benefit Obligation | USD | 244,153 | 2017-12-31 | 2017 | FY | 10-K | 2018-04-02 | 0001213900-18-003895 | |
| us-gaap | DepositsPaidForSecuritiesBorrowedAtCarryingValue | Deposits Paid for Securities Borrowed, at Carrying Value | USD | 260,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-01 | 0001213900-26-038521 | |
| us-gaap | Depreciation | Depreciation | USD | 468,678 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 |
| us-gaap | DepreciationAndAmortization | Depreciation, Depletion and Amortization, Nonproduction | USD | 3.21M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 |
| us-gaap | DepreciationDepletionAndAmortization | Depreciation, Depletion and Amortization | USD | 1.50M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-01 | 0001213900-26-038521 |
| us-gaap | DerivativeLiabilitiesNoncurrent | Derivative Liability, Noncurrent | USD | 934,260 | 2010-12-31 | 2011 | FY | 10-K | 2012-03-14 | 0001010549-12-000255 | |
| us-gaap | DividendsStock | Dividends, Stock | USD | 1.65M | 2023-12-15 | 2023 | FY | 10-K | 2024-04-01 | 0001213900-24-028731 | |
| us-gaap | DueFromOtherRelatedParties | Due from Other Related Parties | USD | 822,062 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-13 | 0001213900-20-036919 | |
| us-gaap | DueFromRelatedParties | Due from Related Parties | USD | 1.12M | 2022-12-31 | 2022 | FY | 10-K | 2023-03-30 | 0001213900-23-024710 | |
| us-gaap | DueToOtherRelatedPartiesClassifiedCurrent | Due to Other Related Parties, Current | USD | 1.35M | 2022-12-31 | 2022 | FY | 10-K | 2023-03-30 | 0001213900-23-024710 | |
| us-gaap | DueToRelatedPartiesCurrent | Due to Related Parties, Current | USD | 2.18M | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-13 | 0001213900-20-036919 | |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -0.12 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | -0.07 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-30 | 0001213900-22-016151 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -0.12 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0.25 | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-13 | 0001213900-23-086100 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.25 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-01 | 0001213900-26-038521 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCredits | Effective Income Tax Rate Reconciliation, Tax Credit, Percent | pure | 0.25 | 2025-01-01 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-12 | 0001213900-25-109203 |
| us-gaap | EffectOfExchangeRateOnCashAndCashEquivalents | Effect of Exchange Rate on Cash and Cash Equivalents | USD | -8,439 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-30 | 0001213900-22-016151 |
| us-gaap | EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | -941 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 |
| us-gaap | EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | USD | -2,606 | 2025-01-01 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-12 | 0001213900-25-109203 |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | USD | 0 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-15 | 0001213900-26-057705 | |
| us-gaap | EmployeeStockOwnershipPlanESOPCompensationExpense | Employee Stock Ownership Plan (ESOP), Compensation Expense | USD | 42,000 | 2022-10-03 | 2023 | FY | 10-K | 2024-04-01 | 0001213900-24-028731 | |
| us-gaap | EquityMethodInvestmentOwnershipPercentage | Equity Method Investment, Ownership Percentage | pure | 1 | 2017-06-30 | 2017 | Q2 | 10-Q | 2017-08-14 | 0001213900-17-008653 | |
| us-gaap | ExcessStockSharesIssued | Excess Stock, Shares Issued | shares | 35,200 | 2021-09-09 | 2023 | FY | 10-K | 2024-04-01 | 0001213900-24-028731 | |
| us-gaap | FairValueNetAssetLiability | Fair Value, Net Asset (Liability) | USD | 65,915 | 2023-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0001213900-24-028731 | |
| us-gaap | FairValueOptionChangesInFairValueGainLoss1 | Fair Value, Option, Changes in Fair Value, Gain (Loss) | USD | 15,243 | 2021-09-01 | 2021-09-09 | 2022 | FY | 10-K | 2023-03-30 | 0001213900-23-024710 |
| us-gaap | FinanceLeasePrincipalPayments | Finance Lease, Principal Payments | USD | 61,958 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 |
| us-gaap | FinanceLeaseWeightedAverageDiscountRatePercent | Finance Lease, Weighted Average Discount Rate, Percent | pure | 0.82 | 2023-09-12 | 2023 | Q3 | 10-Q | 2023-11-13 | 0001213900-23-086100 | |
| us-gaap | FinancingInterestExpense | Financing Interest Expense | USD | 3,584 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 |
| us-gaap | FinancingReceivableModificationToTotalFinancingReceivablesExcludingAccruedInterestPercent | FinancingReceivableModificationToTotalFinancingReceivablesExcludingAccruedInterestPercent | pure | 0.02 | 2023-01-01 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-14 | 0001213900-23-066936 |
| us-gaap | FiniteLivedIntangibleAssetsAccumulatedAmortization | Finite-Lived Intangible Assets, Accumulated Amortization | USD | 9.30M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 | |
| us-gaap | FinitelivedIntangibleAssetsAcquired1 | Finite-lived Intangible Assets Acquired | USD | 6.13M | 2018-01-01 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-30 | 0001213900-20-008020 |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive | Finite-Lived Intangible Asset, Expected Amortization, after Year Five | USD | 11.85M | 2025-12-31 | 2025 | FY | 10-K | 2026-04-01 | 0001213900-26-038521 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths | Finite-Lived Intangible Assets, Amortization Expense, Next Rolling Twelve Months | USD | 269,077 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-30 | 0001010549-16-000541 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths | Finite-Lived Intangible Asset, Expected Amortization, Year One | USD | 2.38M | 2025-12-31 | 2025 | FY | 10-K | 2026-04-01 | 0001213900-26-038521 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive | Finite-Lived Intangible Assets, Amortization Expense, Rolling after Year Five | USD | 183,105 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-30 | 0001010549-16-000541 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive | Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Five | USD | 35,412 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-31 | 0001010549-17-000112 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour | Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Four | USD | 61,288 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-30 | 0001010549-16-000541 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree | Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Three | USD | 117,541 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-30 | 0001010549-16-000541 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo | Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Two | USD | 160,947 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-31 | 0001010549-17-000112 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseYearFive | Finite-Lived Intangible Asset, Expected Amortization, Year Five | USD | 2.38M | 2025-12-31 | 2025 | FY | 10-K | 2026-04-01 | 0001213900-26-038521 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseYearFour | Finite-Lived Intangible Asset, Expected Amortization, Year Four | USD | 2.38M | 2025-12-31 | 2025 | FY | 10-K | 2026-04-01 | 0001213900-26-038521 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseYearThree | Finite-Lived Intangible Asset, Expected Amortization, Year Three | USD | 2.38M | 2025-12-31 | 2025 | FY | 10-K | 2026-04-01 | 0001213900-26-038521 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo | Finite-Lived Intangible Asset, Expected Amortization, Year Two | USD | 2.38M | 2025-12-31 | 2025 | FY | 10-K | 2026-04-01 | 0001213900-26-038521 | |
| us-gaap | FiniteLivedIntangibleAssetsGross | Finite-Lived Intangible Assets, Gross | USD | 46.75M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 | |
| us-gaap | FiniteLivedIntangibleAssetsNet | Finite-Lived Intangible Assets, Net | USD | 359,908 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 | |
| us-gaap | ForeignCurrencyTransactionGainLossBeforeTax | Foreign Currency Transaction Gain (Loss), before Tax | USD | 137,638 | 2024-07-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-13 | 0001213900-24-097461 |
| us-gaap | FurnitureAndFixturesGross | Furniture and Fixtures, Gross | USD | 233,649 | 2013-09-30 | 2013 | Q3 | 10-Q | 2013-11-14 | 0001010549-13-000676 | |
| us-gaap | GainLossOnSaleOfDerivatives | Gain (Loss) on Sale of Derivatives | USD | 0 | 2012-01-01 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-14 | 0001010549-13-000144 |
| us-gaap | GainLossOnSaleOfPropertyPlantEquipment | Gain (Loss) on Disposition of Property Plant Equipment | USD | -2,020 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 3.91M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 |
| us-gaap | GoodwillAndIntangibleAssetImpairment | Goodwill and Intangible Asset Impairment | USD | 0 | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-20 | 0001010549-14-000114 |
| us-gaap | GoodwillImpairmentLoss | Goodwill, Impairment Loss | USD | 17.02M | 2019-01-01 | 2019-12-31 | 2020 | FY | 10-K | 2021-03-26 | 0001213900-21-017981 |
| us-gaap | GovernmentContractReceivable | Government Contract Receivable | USD | 340,000 | 2017-12-31 | 2017 | FY | 10-K | 2018-04-02 | 0001213900-18-003895 | |
| us-gaap | GrossProfit | Gross Profit | USD | 461,027 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 |
| us-gaap | ImpairmentOfIntangibleAssetsExcludingGoodwill | Impairment of Intangible Assets (Excluding Goodwill) | USD | 496,808 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 |
| us-gaap | ImpairmentOfIntangibleAssetsFinitelived | Impairment of Intangible Assets, Finite-lived | USD | 496,808 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 |
| us-gaap | IncomeLossBeforeCumulativeEffectOfChangeInAccountingPrinciple | Income (Loss) before Cumulative Effect of Change in Accounting Principle (Deprecated 2011-01-31) | USD | 22.71M | 2011-01-01 | 2011-12-31 | 2011 | FY | 10-K | 2012-03-14 | 0001010549-12-000255 |
| us-gaap | IncomeLossFromContinuingOperations | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent | USD | -6.23M | 2015-01-01 | 2015-06-30 | 2015 | Q2 | 10-Q | 2015-12-28 | 0001010549-15-000420 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | -4.50M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments | Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest | USD | 17.82M | 2011-01-01 | 2011-09-30 | 2011 | Q3 | 10-Q/A | 2012-03-06 | 0001010549-12-000234 |
| us-gaap | IncomeLossFromContinuingOperationsPerBasicShare | Income (Loss) from Continuing Operations, Per Basic Share | USD/shares | -0.13 | 2016-01-01 | 2016-09-30 | 2016 | Q3 | 10-Q | 2016-11-14 | 0001010549-16-000787 |
| us-gaap | IncomeLossFromContinuingOperationsPerDilutedShare | Income (Loss) from Continuing Operations, Per Diluted Share | USD/shares | -0.13 | 2016-01-01 | 2016-09-30 | 2016 | Q3 | 10-Q | 2016-11-14 | 0001010549-16-000787 |
| us-gaap | IncomeTaxesPaidNet | Income Taxes Paid, Net | USD | 0 | 2015-01-01 | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-12-28 | 0001010549-15-000422 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | -109,989 | 2018-01-01 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-30 | 0001213900-20-008020 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 795,771 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-01 | 0001213900-26-038521 |
| us-gaap | IncomeTaxReconciliationChangeInEnactedTaxRate | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount | USD | 1,119 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-01 | 0001213900-26-038521 |
| us-gaap | IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary | Effective Income Tax Rate Reconciliation, Equity in Earnings (Losses) of Unconsolidated Subsidiary, Amount | USD | 23.30M | 2017-01-01 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001213900-17-012067 |
| us-gaap | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount | USD | -8.09M | 2016-01-01 | 2016-12-31 | 2017 | FY | 10-K | 2018-04-02 | 0001213900-18-003895 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -796,890 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-01 | 0001213900-26-038521 |
| us-gaap | IncomeTaxReconciliationPriorYearIncomeTaxes | Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount | USD | -178,408 | 2018-01-01 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-30 | 0001213900-20-008020 |
| us-gaap | IncomeTaxReconciliationTaxCredits | Effective Income Tax Rate Reconciliation, Tax Credit, Amount | USD | 1.40M | 2012-01-01 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-14 | 0001010549-13-000144 |
| us-gaap | IncomeTaxReconciliationTaxHolidays | Effective Income Tax Rate Reconciliation, Tax Holiday, Amount | USD | 837,089 | 2016-01-01 | 2016-12-31 | 2017 | FY | 10-K | 2018-04-02 | 0001213900-18-003895 |
| us-gaap | IncreaseDecreaseInAccountsAndOtherReceivables | Increase (Decrease) in Accounts and Other Receivables | USD | 259,767 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | 714,380 | 2014-01-01 | 2014-06-30 | 2014 | Q2 | 10-Q | 2014-08-14 | 0001010549-14-000422 |
| us-gaap | IncreaseDecreaseInAccountsPayableAndAccruedLiabilities | Increase (Decrease) in Accounts Payable and Accrued Liabilities | USD | -124,072 | 2014-01-01 | 2014-06-30 | 2014 | Q2 | 10-Q | 2014-08-14 | 0001010549-14-000422 |
| us-gaap | IncreaseDecreaseInAccountsPayableTrade | Increase (Decrease) in Accounts Payable, Trade | USD | -614,642 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 |
| us-gaap | IncreaseDecreaseInAccountsReceivable | Increase (Decrease) in Accounts Receivable | USD | 13.88M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-01 | 0001213900-26-038521 |
| us-gaap | IncreaseDecreaseInAccruedLiabilities | Increase (Decrease) in Accrued Liabilities | USD | 465,753 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-01 | 0001213900-26-038521 |
| us-gaap | IncreaseDecreaseInAccruedTaxesPayable | Increase (Decrease) in Accrued Taxes Payable | USD | 123,921 | 2020-01-01 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-13 | 0001213900-20-036919 |
| us-gaap | IncreaseDecreaseInContractWithCustomerLiability | Increase (Decrease) in Contract with Customer, Liability | USD | -67,004 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 |
| us-gaap | IncreaseDecreaseInCustomerAdvances | Increase (Decrease) in Customer Advances | USD | 1.47M | 2020-01-01 | 2020-03-31 | 2020 | Q1 | 10-Q | 2020-05-14 | 0001213900-20-012258 |
| us-gaap | IncreaseDecreaseInDeferredIncomeTaxes | Increase (Decrease) in Deferred Income Taxes | USD | 67,789 | 2011-01-01 | 2011-09-30 | 2011 | Q3 | 10-Q/A | 2012-03-06 | 0001010549-12-000234 |
| us-gaap | IncreaseDecreaseInDeferredRevenue | Increase (Decrease) in Deferred Revenue | USD | -1.74M | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-30 | 0001010549-16-000541 |
| us-gaap | IncreaseDecreaseInDepositOtherAssets | Increase (Decrease) in Deposit Assets | USD | -17,509 | 2017-01-01 | 2017-03-31 | 2017 | Q1 | 10-Q | 2017-05-11 | 0001010549-17-000167 |
| us-gaap | IncreaseDecreaseInIncomeTaxes | Increase (Decrease) in Income Taxes | USD | 30,334 | 2017-01-01 | 2017-03-31 | 2017 | Q1 | 10-Q | 2017-05-11 | 0001010549-17-000167 |
| us-gaap | IncreaseDecreaseInInventories | Increase (Decrease) in Inventories | USD | -537,154 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 |
| us-gaap | IncreaseDecreaseInInventoryForLongTermContractsOrPrograms | Increase (Decrease) in Inventory for Long-term Contracts or Programs | USD | 231,326 | 2015-01-01 | 2015-06-30 | 2015 | Q2 | 10-Q | 2015-12-28 | 0001010549-15-000420 |
| us-gaap | IncreaseDecreaseInOtherAccountsPayable | Increase (Decrease) in Other Accounts Payable | USD | 0 | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-20 | 0001010549-14-000114 |
| us-gaap | IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities | USD | -142,555 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 |
| us-gaap | IncreaseDecreaseInOtherReceivables | Increase (Decrease) in Other Receivables | USD | -342,012 | 2014-01-01 | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-11-14 | 0001010549-14-000619 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | -1.47M | 2014-01-01 | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-11-14 | 0001010549-14-000619 |
| us-gaap | IncreaseDecreaseInPrepaidExpense | Increase (Decrease) in Prepaid Expense | USD | 44,936 | 2023-01-01 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-14 | 0001213900-23-066936 |
| us-gaap | IncreaseDecreaseInPrepaidExpensesOther | Increase (Decrease) in Prepaid Expenses, Other | USD | 11,653 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 |
| us-gaap | IncreaseDecreaseInPrepaidSupplies | Increase (Decrease) in Prepaid Supplies | USD | 14,078 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 |
| us-gaap | IncrementalCommonSharesAttributableToShareBasedPaymentArrangements | Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements | shares | 0 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-14 | 0001213900-26-090173 |
| us-gaap | IndefiniteLivedIntangibleAssetsPeriodIncreaseDecrease | Indefinite-lived Intangible Assets, Period Increase (Decrease) | USD | 0 | 2015-01-01 | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-12-28 | 0001010549-15-000422 |
| us-gaap | IntangibleAssetsNetExcludingGoodwill | Intangible Assets, Net (Excluding Goodwill) | USD | 37.30M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 | |
| us-gaap | IntangibleAssetsNetIncludingGoodwill | Intangible Assets, Net (Including Goodwill) | USD | 37.30M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 | |
| us-gaap | InterestAndDebtExpense | Interest and Debt Expense | USD | 250,314 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-30 | 0001213900-23-024710 |
| us-gaap | InterestExpense | Interest Expense | USD | 28,804 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 |
| us-gaap | InterestExpenseCustomerDeposits | Interest Expense, Customer Deposits | USD | 105,545 | 2023-04-01 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-14 | 0001213900-23-066936 |
| us-gaap | InterestExpenseDebt | Interest Expense, Debt | USD | 0 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-14 | 0001213900-26-090173 |
| us-gaap | InterestExpenseNonoperating | InterestExpenseNonoperating | USD | 79,506 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 |
| us-gaap | InterestExpenseOther | Interest Expense, Other | USD | 19,844 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 |
| us-gaap | InterestExpenseRelatedParty | Interest Expense, Related Party | USD | 13,546 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-30 | 0001213900-23-024710 |
| us-gaap | InterestIncomeExpenseNet | Interest Income (Expense), Net | USD | 6,773 | 2023-01-01 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-14 | 0001213900-23-066936 |
| us-gaap | InterestIncomeOther | Interest Income, Other | USD | 2,003 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-01 | 0001213900-26-038521 |
| us-gaap | InterestPaid | Interest Paid, Including Capitalized Interest, Operating and Investing Activities | USD | 410,509 | 2017-01-01 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001213900-17-012067 |
| us-gaap | InterestPaidNet | Interest Paid, Excluding Capitalized Interest, Operating Activities | USD | 47,090 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 |
| us-gaap | InventoryAdjustments | Inventory Adjustments | USD | 1.30M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 | |
| us-gaap | InventoryFinishedGoods | Inventory, Finished Goods, Gross | USD | 1.45M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 | |
| us-gaap | InventoryGross | Inventory, Gross | USD | 2.62M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 | |
| us-gaap | InventoryNet | Inventory, Net | USD | 1.32M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 | |
| us-gaap | InventoryRawMaterials | Inventory, Raw Materials, Gross | USD | 869,278 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 | |
| us-gaap | InventoryValuationReserves | Inventory Valuation Reserves | USD | 6.20M | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001213900-17-012067 | |
| us-gaap | InventoryWorkInProcess | Inventory, Work in Process, Gross | USD | 304,884 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 | |
| us-gaap | InventoryWriteDown | Inventory Write-down | USD | 105,987 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 |
| us-gaap | InvestmentIncomeInterest | Investment Income, Interest | USD | 2,390 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 |
| us-gaap | InvestmentInterestRateFloor | InvestmentInterestRateFloor | pure | 0.043 | 2023-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0001213900-24-028731 | |
| us-gaap | LandAndLandImprovements | Land and Land Improvements | USD | 389,808 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-14 | 0001213900-23-066936 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 135,418 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 77,382 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 1,426 | 2019-06-30 | 2019 | Q2 | 10-Q | 2019-08-14 | 0001213900-19-015792 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 38,072 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-01 | 0001213900-26-038521 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 58,036 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 76,144 | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 3,654 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 | |
| us-gaap | LessorOperatingLeasePaymentsToBeReceived | Lessor, Operating Lease, Payments to be Received | USD | 158,100 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-14 | 0001213900-23-066936 | |
| us-gaap | LessorOperatingLeasePaymentsToBeReceivedThreeYears | Lessor, Operating Lease, Payment to be Received, Year Three | USD | 66,056 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-12 | 0001213900-21-058670 | |
| us-gaap | LessorOperatingLeasePaymentsToBeReceivedTwoYears | Lessor, Operating Lease, Payment to be Received, Year Two | USD | 88,075 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-12 | 0001213900-21-058670 | |
| us-gaap | Liabilities | Liabilities | USD | 7.86M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 46.93M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 7.03M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 | |
| us-gaap | LineOfCredit | Long-term Line of Credit | CNY | 3.80M | 2023-12-20 | 2023 | FY | 10-K | 2024-04-01 | 0001213900-24-028731 | |
| us-gaap | LineOfCreditFacilityInterestRateDuringPeriod | Line of Credit Facility, Interest Rate During Period | pure | 0.029 | 2025-09-21 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 | |
| us-gaap | LineOfCreditFacilityMaximumBorrowingCapacity | Line of Credit Facility, Maximum Borrowing Capacity | USD | 4.50M | 2016-04-30 | 2021 | FY | 10-K | 2022-03-30 | 0001213900-22-016151 | |
| us-gaap | LinesOfCreditCurrent | Line of Credit, Current | USD | 2.23M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 | |
| us-gaap | LongTermConstructionLoanCurrent | Long-term Construction Loan, Current | USD | 3.80M | 2022-12-31 | 2022 | FY | 10-K | 2023-03-30 | 0001213900-23-024710 | |
| us-gaap | LongtermConstructionLoanCurrentAndNoncurrent | Long-term Construction Loan | USD | 674,405 | 2019-07-08 | 2019 | Q3 | 10-Q | 2019-11-14 | 0001213900-19-023467 | |
| us-gaap | LongTermDebt | Long-term Debt | USD | 4.33M | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-12 | 0001213900-21-058670 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths | Long-Term Debt, Maturity, Year One | USD | 4.69M | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-13 | 0001213900-21-042474 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive | Long-Term Debt, Maturity, Year Five | USD | 2.21M | 2017-06-30 | 2017 | Q2 | 10-Q | 2017-08-14 | 0001213900-17-008653 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour | Long-Term Debt, Maturity, Year Four | USD | 2.18M | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-14 | 0001213900-18-015783 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree | Long-Term Debt, Maturity, Year Three | USD | 2.12M | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-14 | 0001213900-19-023467 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo | Long-Term Debt, Maturity, Year Two | USD | 4.33M | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-12 | 0001213900-21-058670 | |
| us-gaap | LongTermDebtPercentageBearingFixedInterestRate | Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate | pure | 0.036 | 2026-06-20 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 | |
| us-gaap | LongtermDebtWeightedAverageInterestRate | Long-term Debt, Weighted Average Interest Rate, at Point in Time | pure | 0.85 | 2022-08-03 | 2022 | Q3 | 10-Q | 2022-11-14 | 0001213900-22-072200 | |
| us-gaap | LongTermLineOfCredit | Long-term Line of Credit, Noncurrent | USD | 1.39M | 2024-12-31 | 2025 | FY | 10-K | 2026-04-01 | 0001213900-26-038521 | |
| us-gaap | LossFromCatastrophes | Loss from Catastrophes | USD | 0 | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-30 | 0001010549-16-000541 |
| us-gaap | MachineryAndEquipmentGross | Machinery and Equipment, Gross | USD | 26.76M | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-14 | 0001213900-23-066936 | |
| us-gaap | ManagementAndServiceFeesRate | ManagementAndServiceFeesRate | pure | 0.15 | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-13 | 0001213900-23-086100 |
| us-gaap | MarketableSecuritiesUnrealizedGainLoss | Marketable Securities, Unrealized Gain (Loss) | USD | 39,432 | 2014-01-01 | 2014-03-31 | 2014 | Q1 | 10-Q | 2014-05-15 | 0001010549-14-000242 |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 4.54M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 |
| us-gaap | NetCashProvidedByUsedInFinancingActivitiesContinuingOperations | Net Cash Provided by (Used in) Financing Activities, Continuing Operations | USD | -1.47M | 2017-01-01 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001213900-17-012067 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | -10,880 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 |
| us-gaap | NetCashProvidedByUsedInInvestingActivitiesContinuingOperations | Net Cash Provided by (Used in) Investing Activities, Continuing Operations | USD | -67,324 | 2017-01-01 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001213900-17-012067 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -1.20M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 |
| us-gaap | NetCashProvidedByUsedInOperatingActivitiesContinuingOperations | Net Cash Provided by (Used in) Operating Activities, Continuing Operations | USD | 70,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-01 | 0001213900-26-038521 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -4.50M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | -77,116 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 |
| us-gaap | NotesAndLoansPayable | Notes and Loans Payable | USD | 0 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-26 | 0001213900-21-017981 | |
| us-gaap | NotesPayable | Notes Payable | USD | 1.18M | 2021-09-09 | 2022 | FY | 10-K | 2023-03-30 | 0001213900-23-024710 | |
| us-gaap | NotesPayableCurrent | Notes Payable, Current | USD | 0 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-31 | 0001010549-17-000112 | |
| us-gaap | NotesPayableRelatedPartiesClassifiedCurrent | Notes Payable, Related Parties, Current | USD | 951,506 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-30 | 0001213900-23-024710 | |
| us-gaap | NotesPayableRelatedPartiesNoncurrent | Notes Payable, Related Parties, Noncurrent | USD | 372,578 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-30 | 0001213900-23-024710 | |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 4.89M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -4.43M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 |
| us-gaap | OperatingLeaseCost | Operating Lease, Cost | USD | 17,986 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-15 | 0001213900-26-057705 |
| us-gaap | OperatingLeaseLeaseIncome | Operating Lease, Lease Income | USD | 75,154 | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-12 | 0001213900-21-058670 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 131,764 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 74,447 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 57,317 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 | |
| us-gaap | OperatingLeasePayments | Operating Lease, Payments | USD | 18,830 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-15 | 0001213900-26-057705 |
| us-gaap | OperatingLeasePaymentsUse | Operating Lease, Payments, Use | USD | 117,637 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0001213900-24-028731 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 129,348 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 | |
| us-gaap | OperatingLeaseRightOfUseAssetAmortizationExpense | Operating Lease, Right-of-Use Asset, Amortization Expense | USD | 59,365 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDue | Operating Leases, Future Minimum Payments Due | USD | 178,357 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-13 | 0001213900-21-042474 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueCurrent | Operating Leases, Future Minimum Payments Due, Next Twelve Months | USD | 95,986 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-30 | 0001213900-20-008020 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInThreeYears | Operating Leases, Future Minimum Payments, Due in Three Years | USD | 88,420 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-13 | 0001213900-21-042474 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInTwoYears | Operating Leases, Future Minimum Payments, Due in Two Years | USD | 89,937 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-13 | 0001213900-21-042474 | |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0.03 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 | |
| us-gaap | OperatingLossCarryforwards | Operating Loss Carryforwards | USD | 4.30M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 | |
| us-gaap | OperatingLossCarryforwardsValuationAllowance | Operating Loss Carryforwards, Valuation Allowance | USD | 5.10M | 2023-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0001213900-24-028731 | |
| us-gaap | OptionIndexedToIssuersEquityIndexedShares | Option Indexed to Issuer's Equity, Indexed Shares | shares | 13,300 | 2023-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0001213900-24-028731 | |
| us-gaap | OtherCashEquivalentsAtCarryingValue | Other Cash Equivalents, at Carrying Value | USD | 700,000 | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-14 | 0001213900-24-068984 | |
| us-gaap | OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax (Deprecated 2012-01-31) | USD | 3.04M | 2013-01-01 | 2013-06-30 | 2013 | Q2 | 10-Q | 2013-08-14 | 0001010549-13-000521 |
| us-gaap | OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax | USD | 675 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 |
| us-gaap | OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax | USD | 1.46M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 |
| us-gaap | OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax | Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax | USD | 408,746 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 |
| us-gaap | OtherComprehensiveIncomeLossNetOfTax | Other Comprehensive Income (Loss), Net of Tax | USD | -2.05M | 2018-01-01 | 2018-06-30 | 2018 | Q2 | 10-Q | 2018-08-14 | 0001213900-18-010992 |
| us-gaap | OtherComprehensiveIncomeLossTax | Other Comprehensive Income (Loss), Tax | USD | -6.10M | 2015-01-01 | 2015-06-30 | 2015 | Q2 | 10-Q | 2015-12-28 | 0001010549-15-000420 |
| us-gaap | OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent | Other Deferred Compensation Arrangements, Liability, Classified, Noncurrent | USD | 375,351 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-14 | 0001213900-23-066936 | |
| us-gaap | OtherDeferredCompensationArrangementsLiabilityCurrent | Other Deferred Compensation Arrangements, Liability, Current | USD | 959,506 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-14 | 0001213900-23-066936 | |
| us-gaap | OtherEmployeeRelatedLiabilitiesCurrent | Other Employee-related Liabilities, Current | USD | 1.94M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 | |
| us-gaap | OtherExpenses | Other Expenses | USD | 126,808 | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-14 | 0001213900-18-006100 |
| us-gaap | OtherLiabilities | Other Liabilities | USD | 2.24M | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-14 | 0001213900-23-066936 | |
| us-gaap | OtherLiabilitiesCurrent | Other Liabilities, Current | USD | 2.45M | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-14 | 0001213900-23-066936 | |
| us-gaap | OtherLoansPayable | Other Loans Payable | CNY | 30.00M | 2016-04-30 | 2017 | Q2 | 10-Q | 2017-08-14 | 0001213900-17-008653 | |
| us-gaap | OtherNotesPayable | Other Notes Payable | USD | 959,506 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-14 | 0001213900-23-066936 | |
| us-gaap | OtherNotesPayableCurrent | Other Notes Payable, Current | USD | 8.18M | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-14 | 0001213900-23-066936 | |
| us-gaap | OtherOperatingActivitiesCashFlowStatement | Other Operating Activities, Cash Flow Statement | USD | 95,985 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-30 | 0001213900-20-008020 |
| us-gaap | OtherReceivablesNetCurrent | Other Receivables, Net, Current | USD | 84,244 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 | |
| us-gaap | OtherRestrictedAssetsCurrent | Other Restricted Assets, Current | USD | 14,513 | 2017-03-31 | 2017 | Q1 | 10-Q | 2017-05-11 | 0001010549-17-000167 | |
| us-gaap | OtherTaxExpenseBenefit | Other Tax Expense (Benefit) | USD | 178,408 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-28 | 0001213900-19-005094 |
| us-gaap | PaymentsForAdvanceToAffiliate | Payments for Advance to Affiliate | CNY | 3.80M | 2024-11-11 | 2025 | FY | 10-K | 2026-04-01 | 0001213900-26-038521 | |
| us-gaap | PaymentsForConstructionInProcess | Payments for Construction in Process | USD | -310,247 | 2015-01-01 | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-12-28 | 0001010549-15-000422 |
| us-gaap | PaymentsForFees | Payments for Other Fees | USD | 10,934 | 2024-05-23 | 2025 | FY | 10-K | 2026-04-01 | 0001213900-26-038521 | |
| us-gaap | PaymentsForLoans | Payments for Loans | USD | 738,379 | 2019-07-08 | 2025 | Q3 | 10-Q | 2025-11-12 | 0001213900-25-109203 | |
| us-gaap | PaymentsForMortgageDeposits | Payments for Mortgage Deposits | CNY | 856,660 | 2020-10-31 | 2023 | FY | 10-K | 2024-04-01 | 0001213900-24-028731 | |
| us-gaap | PaymentsForProceedsFromProductiveAssets | Payments for (Proceeds from) Productive Assets | USD | 18,866 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-13 | 0001213900-24-097461 |
| us-gaap | PaymentsOfDividendsPreferredStockAndPreferenceStock | Payments of Ordinary Dividends, Preferred Stock and Preference Stock | USD | -38,145 | 2014-01-01 | 2014-03-31 | 2014 | Q1 | 10-Q | 2014-05-15 | 0001010549-14-000242 |
| us-gaap | PaymentsToAcquireIntangibleAssets | Payments to Acquire Intangible Assets | USD | 72,614 | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 |
| us-gaap | PaymentsToAcquireMarketableSecurities | Payments to Acquire Marketable Securities | USD | -5.40M | 2014-01-01 | 2014-03-31 | 2014 | Q1 | 10-Q | 2014-05-15 | 0001010549-14-000242 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 10,880 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 |
| us-gaap | PreconfirmationAccumulatedOtherComprehensiveIncomeLoss | Preconfirmation, Accumulated Other Comprehensive Income (Loss) | USD | 15.63M | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-14 | 0001213900-18-006100 | |
| us-gaap | PreferredStockConvertibleSharesIssuable | PreferredStockConvertibleSharesIssuable | shares | 1.52M | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-14 | 0001213900-22-072200 | |
| us-gaap | PreferredStockNoParValue | Preferred Stock, No Par Value | USD/shares | 0.001 | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-11-14 | 0001010549-14-000619 | |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0.001 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 | |
| us-gaap | PreferredStockRedemptionAmount | Preferred Stock, Redemption Amount | USD | 200,000 | 2022-08-03 | 2022 | Q3 | 10-Q | 2022-11-14 | 0001213900-22-072200 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 5.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2017-03-31 | 2017 | Q1 | 10-Q | 2017-05-11 | 0001010549-17-000167 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2017-03-31 | 2017 | Q1 | 10-Q | 2017-05-11 | 0001010549-17-000167 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 0 | 2017-03-31 | 2017 | Q1 | 10-Q | 2017-05-11 | 0001010549-17-000167 | |
| us-gaap | PrepaidExpenseCurrent | Prepaid Expense, Current | USD | 88,401 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 | |
| us-gaap | PrepaidExpenseCurrentAndNoncurrent | Prepaid Expense | USD | 404,370 | 2014-12-31 | 2014 | FY | 10-K | 2015-12-28 | 0001010549-15-000416 | |
| us-gaap | PrepaymentFeesOnAdvancesNet | Prepayment Fees on Advances, Net | USD | -714,697 | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-12-28 | 0001010549-15-000416 |
| us-gaap | ProceedsFromConstructionLoansPayable | Proceeds from Construction Loans Payable | USD | -145,176 | 2017-01-01 | 2017-03-31 | 2017 | Q1 | 10-Q | 2017-05-11 | 0001010549-17-000167 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 4.38M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 |
| us-gaap | ProceedsFromIssuanceOfConvertiblePreferredStock | Proceeds from Issuance of Convertible Preferred Stock | USD | 5.00M | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-30 | 0001213900-23-024710 |
| us-gaap | ProceedsFromLinesOfCredit | Proceeds from Lines of Credit | USD | 1.46M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 |
| us-gaap | ProceedsFromLoans | Proceeds from Loans | USD | 604,756 | 2014-01-01 | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-11-14 | 0001010549-14-000619 |
| us-gaap | ProceedsFromLongTermLinesOfCredit | Proceeds from Long-term Lines of Credit | CNY | 10.00M | 2026-09-17 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 | |
| us-gaap | ProceedsFromNotesPayable | Proceeds from Notes Payable | USD | 0 | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-20 | 0001010549-14-000114 |
| us-gaap | ProceedsFromRelatedPartyDebt | Proceeds from Related Party Debt | USD | 218,489 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 |
| us-gaap | ProceedsFromRepaymentsOfLinesOfCredit | Proceeds from (Repayments of) Lines of Credit | USD | 505,114 | 2023-01-01 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-14 | 0001213900-23-066936 |
| us-gaap | ProceedsFromRepaymentsOfRelatedPartyDebt | Proceeds from (Repayments of) Related Party Debt | USD | -77,530 | 2020-01-01 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-13 | 0001213900-20-036919 |
| us-gaap | ProceedsFromSaleAndMaturityOfMarketableSecurities | Proceeds from Sale and Maturity of Marketable Securities | USD | 5.21M | 2014-01-01 | 2014-03-31 | 2014 | Q1 | 10-Q | 2014-05-15 | 0001010549-14-000242 |
| us-gaap | ProceedsFromShortTermDebt | Proceeds from Short-term Debt | USD | -4.52M | 2016-01-01 | 2016-12-31 | 2017 | FY | 10-K | 2018-04-02 | 0001213900-18-003895 |
| us-gaap | ProceedsFromWarrantExercises | Proceeds from Warrant Exercises | USD | 2.58M | 2010-01-01 | 2010-12-31 | 2011 | FY | 10-K | 2012-03-14 | 0001010549-12-000255 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -593,029 | 2023-04-01 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-14 | 0001213900-23-066936 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 39.49M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 4.12M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 | |
| us-gaap | PropertyPlantAndEquipmentOther | Property, Plant and Equipment, Other, Gross | USD | 3.15M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 | |
| us-gaap | PropertyPlantAndEquipmentOtherNet | Property, Plant and Equipment, Other, Net | USD | 7.10M | 2023-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0001213900-24-028731 | |
| us-gaap | ProvisionForDoubtfulAccounts | Accounts Receivable, Credit Loss Expense (Reversal) | USD | 12,270 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 |
| us-gaap | ProvisionForOtherCreditLosses | Provision for Other Credit Losses | USD | 6,128 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 |
| us-gaap | ProvisionForOtherLosses | Provision for Other Losses | USD | -13.70M | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 |
| us-gaap | ReceivablesNetCurrent | Receivables, Net, Current | USD | 91,753 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-14 | 0001213900-23-066936 | |
| us-gaap | ReceivableWithImputedInterestNetAmount | Receivable with Imputed Interest, Net Amount | USD | 5,699 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-14 | 0001213900-23-066936 | |
| us-gaap | RelatedPartyTransactionAmountsOfTransaction | Related Party Transaction, Amounts of Transaction | USD | 1.10M | 2023-01-01 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-14 | 0001213900-23-066936 |
| us-gaap | RepaymentsOfConstructionLoansPayable | Repayments of Construction Loans Payable | USD | 2.33M | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-30 | 0001213900-23-024710 |
| us-gaap | RepaymentsOfLinesOfCredit | Repayments of Lines of Credit | USD | 1.30M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 |
| us-gaap | RepaymentsOfLongTermLinesOfCredit | Repayments of Long-term Lines of Credit | CNY | 1.10M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-01 | 0001213900-26-038521 |
| us-gaap | RepaymentsOfNotesPayable | Repayments of Notes Payable | USD | -3.84M | 2010-01-01 | 2010-12-31 | 2011 | FY | 10-K | 2012-03-14 | 0001010549-12-000255 |
| us-gaap | RepaymentsOfRelatedPartyDebt | Repayments of Related Party Debt | USD | 154,114 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 |
| us-gaap | RepaymentsOfShortTermDebt | Repayments of Short-term Debt | CNY | 551,250 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-14 | 0001213900-26-090173 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 119,266 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 |
| us-gaap | RestrictedCash | Restricted Cash | USD | 222,996 | 2020-06-30 | 2021 | Q2 | 10-Q | 2021-08-13 | 0001213900-21-042474 | |
| us-gaap | RestrictedCashAndCashEquivalents | Restricted Cash and Cash Equivalents | USD | 957,653 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-26 | 0001213900-21-017981 | |
| us-gaap | RestrictedCashAndCashEquivalentsAtCarryingValue | Restricted Cash and Cash Equivalents, Current | USD | 900,000 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-14 | 0001213900-23-066936 | |
| us-gaap | RestrictedCashCurrent | Restricted Cash, Current | USD | 331,038 | 2020-03-31 | 2021 | Q1 | 10-Q | 2021-05-14 | 0001213900-21-026413 | |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -51.72M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 | |
| us-gaap | RetainedEarningsAppropriated | Retained Earnings, Appropriated | USD | -41.70M | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-14 | 0001213900-24-068984 | |
| us-gaap | RevenueFromGrants | Revenue from Grants (Deprecated 2018-01-31) | USD | 348,672 | 2016-01-01 | 2016-06-30 | 2017 | Q2 | 10-Q | 2017-08-14 | 0001213900-17-008653 |
| us-gaap | Revenues | Revenues | USD | 3.08M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 214,070 | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 |
| us-gaap | SaleOfStockConsiderationReceivedPerTransaction | Sale of Stock, Consideration Received Per Transaction | USD | 5.00M | 2021-11-01 | 2021-11-17 | 2022 | FY | 10-K | 2023-03-30 | 0001213900-23-024710 |
| us-gaap | SaleOfStockNumberOfSharesIssuedInTransaction | Sale of Stock, Number of Shares Issued in Transaction | shares | 6,267 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0001213900-24-028731 |
| us-gaap | SaleOfStockPricePerShare | Sale of Stock, Price Per Share | USD/shares | 0.55 | 2023-12-15 | 2023 | FY | 10-K | 2024-04-01 | 0001213900-24-028731 | |
| us-gaap | SellingExpense | Selling Expense | USD | 343,644 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 0 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-14 | 0001213900-26-090173 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | pure | 1.184 | 2021-09-01 | 2021-09-09 | 2022 | FY | 10-K | 2023-03-30 | 0001213900-23-024710 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | pure | 0.038 | 2022-10-04 | 2022 | FY | 10-K | 2023-03-30 | 0001213900-23-024710 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate | pure | 1.155 | 2022-10-04 | 2022 | FY | 10-K | 2023-03-30 | 0001213900-23-024710 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant | Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant | shares | 559,800 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-14 | 0001213900-26-090173 | |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 82 | 2023-06-01 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-14 | 0001213900-23-066936 |
| us-gaap | ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedVolatilityRate | Share-based Goods and Nonemployee Services Transaction, Valuation Method, Expected Volatility Rate | pure | 1.155 | 2022-10-04 | 2023 | FY | 10-K | 2024-04-01 | 0001213900-24-028731 | |
| us-gaap | ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate | Share-based Goods and Nonemployee Services Transaction, Valuation Method, Risk Free Interest Rate | pure | 0.038 | 2022-10-04 | 2023 | FY | 10-K | 2024-04-01 | 0001213900-24-028731 | |
| us-gaap | SharePrice | Share Price | USD/shares | 2 | 2026-07-22 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 | |
| us-gaap | SharesIssued | Shares, Issued | shares | 6,425 | 2022-03-23 | 2023 | FY | 10-K | 2024-04-01 | 0001213900-24-028731 | |
| us-gaap | SharesIssuedPricePerShare | Shares Issued, Price Per Share | USD/shares | 0.455 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-13 | 0001213900-24-097461 | |
| us-gaap | ShortTermBankLoansAndNotesPayable | Short-term Bank Loans and Notes Payable | CNY | 3.00M | 2021-07-12 | 2021 | FY | 10-K | 2022-03-30 | 0001213900-22-016151 | |
| us-gaap | ShortTermBorrowings | Short-term Debt | USD | 1.57M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 | |
| us-gaap | ShortTermDebtPercentageBearingFixedInterestRate | Short-term Debt, Percentage Bearing Fixed Interest Rate | pure | 0.033 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 | |
| us-gaap | StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired | Statutory Accounting Practices, Statutory Capital and Surplus Required | USD | 8.14M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 | |
| us-gaap | StatutoryAccountingPracticesStatutoryNetIncomeAmount | Statutory Accounting Practices, Statutory Net Income Amount | USD | 8.14M | 2023-01-01 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-14 | 0001213900-23-066936 |
| us-gaap | StockGrantedDuringPeriodValueSharebasedCompensationForfeited | Shares Granted, Value, Share-based Payment Arrangement, Forfeited | USD | 36,270 | 2022-10-04 | 2023 | FY | 10-K | 2024-04-01 | 0001213900-24-028731 | |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 39.07M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 | |
| us-gaap | StockholdersEquityNoteSubscriptionsReceivable | Stockholders' Equity Note, Subscriptions Receivable | USD | 180,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 | |
| us-gaap | StockIssued1 | Stock Issued | USD | 14.99M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 |
| us-gaap | StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities | Stock Issued During Period, Shares, Conversion of Convertible Securities | shares | 78,333 | 2023-06-01 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-14 | 0001213900-23-066936 |
| us-gaap | StockIssuedDuringPeriodSharesConversionOfUnits | Stock Issued During Period, Shares, Conversion of Units | shares | 126,667 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-30 | 0001213900-23-024710 |
| us-gaap | StockIssuedDuringPeriodSharesNewIssues | Stock Issued During Period, Shares, New Issues | shares | 81,576 | 2024-12-09 | 2025 | FY | 10-K | 2026-04-01 | 0001213900-26-038521 | |
| us-gaap | StockIssuedDuringPeriodValueAcquisitions | Stock Issued During Period, Value, Acquisitions | USD | 1.65M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0001213900-24-028731 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | Stock Issued During Period, Value, Conversion of Convertible Securities | USD | 1.47M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-04-01 | 0001213900-26-038521 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfUnits | Stock Issued During Period, Value, Conversion of Units | USD | 1.85M | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0001213900-25-026280 |
| us-gaap | StockIssuedDuringPeriodValueIssuedForServices | Stock Issued During Period, Value, Issued for Services | USD | 800,000 | 2023-04-01 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-14 | 0001213900-23-066936 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 4.38M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 |
| us-gaap | StockIssuedDuringPeriodValueOther | Stock Issued During Period, Value, Other | USD | 42,000 | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0001213900-24-028731 |
| us-gaap | StockIssuedDuringPeriodValueShareBasedCompensation | Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture | USD | 36,270 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-30 | 0001213900-23-024710 |
| us-gaap | StockOptionExercisePriceIncrease | Stock Option, Exercise Price, Increase | USD/shares | 28 | 2022-10-04 | 2023 | FY | 10-K | 2024-04-01 | 0001213900-24-028731 | |
| us-gaap | StockOptionPlanExpense | Stock or Unit Option Plan Expense | USD | 78,270 | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0001213900-24-028731 |
| us-gaap | StockRepurchasedDuringPeriodShares | Stock Repurchased During Period, Shares | shares | 2.50M | 2026-07-22 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 | |
| us-gaap | Supplies | Prepaid Supplies | USD | 1.05M | 2020-03-31 | 2020 | Q1 | 10-Q | 2020-05-14 | 0001213900-20-012258 | |
| us-gaap | TaxBenefitFromStockOptionsExercised | Tax Benefit from Stock Options Exercised (Deprecated 2012-01-31) | USD | 5.86M | 2012-01-01 | 2012-09-30 | 2012 | Q3 | 10-Q | 2012-11-14 | 0001010549-12-001213 |
| us-gaap | TaxCreditCarryforwardAmount | Tax Credit Carryforward, Amount | USD | 7.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 | |
| us-gaap | TaxesPayableCurrent | Taxes Payable, Current | USD | 326,951 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 | |
| us-gaap | TradeReceivablesHeldForSaleNet | Disposal Group, Including Discontinued Operation, Trade Receivables (Deprecated 2015-01-31) | USD | 52.52M | 2013-09-30 | 2013 | Q3 | 10-Q | 2013-11-14 | 0001010549-13-000676 | |
| us-gaap | UndistributedEarnings | Undistributed Earnings, Basic | USD | 26.30M | 2017-01-01 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001213900-17-012067 |
| us-gaap | UnrecognizedTaxBenefitsResultingInNetOperatingLossCarryforward | Unrecognized Tax Benefits Resulting in Net Operating Loss Carryforward (Deprecated 2014-01-31) | USD | 3.35M | 2013-06-30 | 2013 | Q2 | 10-Q | 2013-08-14 | 0001010549-13-000521 | |
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | 2.41M | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-30 | 0001010549-16-000541 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 36.90M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 46.13M | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-30 | 0001213900-22-016151 |
| us-gaap | WeightedAverageNumberOfSharesIssuedBasic | Weighted Average Number of Shares Issued, Basic | shares | 43.58M | 2013-01-01 | 2013-06-30 | 2013 | Q2 | 10-Q | 2013-08-14 | 0001010549-13-000521 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 36.90M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-18 | 0001213900-26-121812 |